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A bstract
It is commonly accepted that, on ageing, the body’s proteins become 
structuredly altered. One such protein predominating throughout the 
body is collagen. This long-Hved protein forms a major part of the 
human cornea and sclera and it is within these tissues that the work 
of this thesis has revealed age-related structural and biochemical 
modifications of type I collagen. Using the highly sensitive technique 
of X-ray diffraction, the size of the intermolecular unit cell of the 
collagen has been demonstrated to increase in both tissues from birth 
to 90 years of age. Across the same age range, the volume of the fibril 
unit cell of corneal collagen ha.s been found to decrease. In an 
attem pt to account for the molecular changes, the concept of 
sugar-induced structural modification (glycation) weis investigated 
using a colorimetric assay. This too was found to increase with tissue 
age as did the production of fluorescent cross-Hnks (possibly 
intermolecular) on the collagen. These fluorescent structures were 
quantified by their fluorescence emission properties. Different sugars 
were also used, to compare their effects on the intermolecular unit cell 
volume. Since collagen is a family of proteins, the glycation of two 
different collagen types was studied. Several chemical compounds 
were also used to investigate the inhibition of in vitro glycation of 
collagen. The absence of an increase in intermolecular unit cell 
volume in the presence of these compounds suggests that it may be 
possible to control this particular consequence of ageing. The 
literature suggests that interfibriHar spacing is linked with corneal 
transparency. Proteoglycans are essentially involved in controlling 
this particular spacing and the work of this thesis has shown no 
significant loss of these macromolecules to the organ culture medium 
in which the tissue is housed before investigation. Tissue 
proteoglycan may be lost during the natural ageing of an individual.
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oChapter 1
Introduction
This thesis is concerned with the ageing of collagen within the human 
cornea and sclera and in particular how the collagen of these eye tissues is 
altered both structurally and biochemically with age. This chapter will deal 
with the structure and composition of both the cornea and sclera and will 
outline the aims of the experiments undertaken.
1.1 The human eye
Figure 1.1 illustrates a horizontal cross-section through a vertebrate eye. It 
is spherical in shape and in human adults has a diameter of approximately 
24mm. The globe is covered posteriorly by the sclera which is the tough, 
white, opaque coat serving to protect the eye. Anteriorly the globe is 
covered by a transparent layer, the cornea. Light passes through the cornea 
and the transparent aqueous humor, which hues the posterior of the cornea, 
and eventually reaches another transparent structure, the lens. The lens 
serves to focus incoming images onto the retina. Posterior to the lens is 
another transparent medium, the vitreous which occupies approximately 
90% of the total volume of the eye and not only provides strong structural 
support but also protects against mechanical impact.
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1.2 Structure o f th e cornea
The côrnea is composed of 5 distinct anatomical layers as illustrated in 
Figure 1.2. These layers lie parallel to the corneal surface and are further 
described below.
1.2.1 E pithelium
This is the outermost layer which contributes 8-10% of the total corneal 
thickness in mammals. Although the number of cell layers can vary from 
species to species the cell types are essentially columnar and squamous. 
The epithelium’s primary function is, with the tear film, to provide a very 
smooth refracting surface at the front of the eye. Its barrier function 
reduces evaporation and minimises absorption of fluid from the tears, thus 
helping to maintain proper corneal hydration.
1.2.2 Basal lam ina
Also known as Bowman’s layer, this is a basement membrane underlying 
the epithehum. It consists of a disordered array of collagen fibrils and is a 
relatively thin membrane when compared to the total corneal thickness.
1.2.3 Strom a
The stroma comprises 90% of the total corneal thickness and consists of 
lamellae which are arranged such that they lie parallel to the surface 
[Jakus, 1954]. Within each lamella the collagen fibrils are of uniform 
diameter and lie parallel to each other but not to those of neighbouring 
lamellae. The normal human corneal stroma contains 78% water [Maurice, 
1984] and the major structural constituents are collagen and proteoglycans, 
which comprise 12-15% and 1-3%, respectively, of the wet weight of the 
tissue. Non-collagenous structural proteins, soluble proteins, glycoproteins
11
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cand lipids axe also present together with electrolytes, commonly sodium 
and chloride ions. These ions play an important role in comeal hydration 
[Maurice, 1984]..
1.2.4 D escem et’s m em brane
This is a basement membrane produced by the endothelial cells [Kapoor et 
al., 1986]. The thickness varies with age from approximately 3/xm in young 
humans to 9-10/im in adults [Murphy et al., 1984]. The membrane contains 
both laminin and fibronectin. The principal collagen type found here is 
type VIII [Labermeier and Kenney, 1983] although type IV has also been 
identified [Labermeier et al., 1983].
1.2.5 E ndothelium
This is a single layer of hexagonally-shaped cells located on Descemet’s 
membrane and found to be lining the posterior surface of the cornea. The 
corneal endothelium plays an important role in maintaining corneal 
dehydration and transparency by continuously pumping fluid and ions out 
of the stroma into the aqueous.
1.3 Structure o f the sclera
Figure 1.3 illustrates the different architecture of the cornea and sclera.
The sclera is less hydrated than the cornea so 75% of its dry weight is made 
up of collagen, 10% by other proteins and 1% by proteoglycans. Type I 
collagen predominates although types III and V exist in sclera. A greater 
proportion of type III coUagen is found here compared with the cornea. 
There is a suggestion that type III imparts elasticity to the tissue. Type VI 
coUagen has been found localised to the fUamentous strands in the scleral 
interfibriUar m atrix [MarshaU and Lee, 1993]. As with the cornea, fibrous
14
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bands of collagen run across the Hmbus. However, unlike the 
highly-organized collagen of the cornea, the sclera contains collagen fibres 
that divide and recombine, frequently giving the appearance of an 
interlaced structure. These bands are a continuation of the comeal 
lamellae. The sclera contains numerous elastic fibres running parallel to the 
collagen [Virchow, 1910]. Within sclerà the collagen fibres are also of 
unequal diameter and can vary from 30-300nm [Schwarz, 1953a,bj. Unlike 
the cornea, the fibrils are covered by a thinner coating of ground substance 
and less proteoglycan is found here too. The sclera itself is almost 
avascular, however it does possess a looser outer coat in which there is a 
well-developed network of vessels near the corneal margin. Throughout the 
scleral tissue, fixed cells similar to those of the cornea exist together with 
pigmented cells commonly found in the choroid.
1,4 Corneal transparency
Although the outer protective coat of the eye is formed by both the cornea 
and sclera, it is the former tissue which is transparent to light. The cornea 
transmits approximately 90% of light in the visible spectrum. The need for 
corneal transparency is obvious, however the mechanism by which this is 
achieved has long been debated. The lack of blood and lymph vessels, the 
absence of myelin sheaths around the corneal nerves, and proper hydration 
of the stroma are certainly necessary. Other connective tissues have similar 
mixtures of collagen fibrils and ground substance, for example sclera, yet 
the corneal stroma remains transparent.
During the early stages of development the cornea and sclera possess 
collagen fibrils of equal diameter [Smelser, 1960] and both tissues appear to 
be translucent. As development progresses, the fibrils of the cornea become 
narrow and attain a uniform diameter of approximately 35-39nm [Craig et 
al., 1987] and the tissue remains transparent, unhke scleral tissue. The 
coUagen fibrils of the sclera continue to grow and result in a large range of 
fibril diameters.
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Maurice (1957) suggested that the tight packing and regular lattice 
arrangement of the corneal stromal collagen fibrils is responsible for corneal 
transparency. Light scattered by individual fibres is cancelled by destructive 
interference with scattered hght from neighbouring fibres. As long as the 
fibres are regularly arranged and separated by less than a wavelength of 
light, the cornea wiU remain transparent. However, if the stroma becomes 
edematous, the space between the fibres increases, destructive interference 
no longer occurs, light is scattered and corneal transparency is reduced. It 
must be noted however, that a regular lattice arrangement of the coUagen 
fibres does not occur in Bowman’s layer. Goldman and Benedek (1968) 
concluded that significant light scattering did not occur unless there were 
appreciable regional fluctuations in refractive index.
The corneal stroma does not scatter Hght because its coUagen fibrils are 
smaU in diameter (approx 35-39nm), uniformly packed and closely spaced 
(approx 55nm).
1.5 Control o f strom al hydration
The control of corneal stromal hydration is essential for transparency.
Water accounts for 78% of the weight of the cornea, higher than most 
connective tissue elsewhere in the body. The hydration (H) can be 
described as the ratio of water (by weight) to dry weight of tissue. The 
physiological hydration of normal human cornea is taken to be 3.2 [Meek et 
al., 1991] and if this is increased, the thickness of the tissue increases too 
(at H=6.8 corneal thickness doubles). The mechanisms which play a role in 
the regulation of corne«d hydration (iUustrated in Figure 1.4) are :
a. barrier function of the epithehum and endothehum - both these ceU 
layers act as barriers to the movement of water and ions into the stroma.
b. sweUing pressure of the stroma - this is controUed by the 
glycosaminoglycans of the ground substance.
c. ionic transport by the epithehum cind endothehum - the mechanism in 
the endothehum is one of active transport of ions from the stroma into the
17
aqueous, with, passive, secondary movements of water. This creates an 
osmotic gradient which balances the swelling pressure of the corneal stroma 
[Fischbarg et al., 1985].
d. intraocular pressure - when intraocular pressure exceeds the stromal 
swelling pressure epithelial edema occurs, the anterior stromal lamellae are 
thought to bear the stress of the intraocular pressure [McPhee et al., 1985].
e. evaporation of water from the comeal surface - evaporation of water 
from the tear film results in hypertonicity of the tears and draws water 
from the epithelial cells, and subsequently the stroma.
Epitfaeiial 
ioo transport
Epitbdiai
barrie*
Tear film 
evaporation
Tears—. 
EpitheUum — T
Stroma
Endothelium
Stromal swelling 
pressure
Endothelial
barrier Endothelial 
ion transport
F ig u re  1.4 Diagrammatic representation of the control of corneal stromal 
hydration
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c
1.6 Collagen
Collagen is a major constituent of all extracellular matrices and is of great 
importance structurally. The term collagen refers to a complex family of 
genetically distinct proteins. To date, seventeen types of collagen have been 
described and characterized to varying degrees.
1.6.1 T he collagen m olecule
The shape and most of the structural properties of a native collagen 
molecule are determined by its triple-heHcal domain(s). The fibril-forming 
coUagens possess a single triple-heHcal domain which comprises more than 
95% of the molecule (Figure 1.5).
Other coUagens have multiple triple-heHcal domains and these may 
represent only a fraction of the mass of the molecule. A triple-heHcal or 
coUagenous domain consists of three separate chains ( a  chains), each of 
which contains a characteristic sequence of amino acids twisted in the form 
of a left-handed helix [Ramachandran and Ramakrishnan, 1976]. The three 
heHcal chains are wrapped around one another to produce a higher-order 
tight, triple-heHcal structure of the molecule [Traub and Piez, 1971]. This 
conformation is stabiHzed by interchain hydrogen bonds. These are the 
bonds that are disrupted during thermal and chemical dénaturation, 
resulting in unfolding of the molecule. Folding of the component a  chains 
requires glycine as every third ainino acid residue. The a  chains exist 
therefore as a series of triplet Gly-X-Y sequences in which X or Y can be 
any amino acid. Frequently, X is proHne and Y is hydroxyproHne. A large 
number of hydroxyproHne residues adds stabiHty to the heHcal structure 
whilst lysine and its enzymaticaUy-modified forms participate in covalent 
cross-Hnking between chains and molecules, and act as sites for sugar 
attachment.
The coUagen molecules spontaneously self-assemble tu form fibriUar 
structures in a characteristic quarter-stagger arrangement. When examined
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F igure  1.5 Diagram of the major characteristics of the type I collagen 
molecule. OH-PRO, hydroxyproHne; OH-LYS, hydroxylysine; GAL, galac­
tose; GLU, glucose (from Cell Biology of the Extracellular Matrix, 1991)
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by electron microscopy, collagen fibrils exhibit a characteristic transverse 
banding pattern as shown in Figure 1.6.
The diagram illustrates the staggered packing arrangement of the molecules 
in the fibrils as suggested by Hodge and Petruska in 1963. Low angle X-ray 
diffraction patterns give a series of meridional reflections that indicate that 
the feature responsible for this banding pattern has a periodicity (D) of 
67nm in rat tail tendon and sclera, whilst it has a value of 65nm in cornea. 
Since the individual collagen molecules are around SOOnm in length, the 
periodicity has been attributed to an arrangement in which the molecules 
are axially staggered. Since the molecular length is not an exact multiple of 
D=67nm, there are abrupt changes in electron density at intervals of 
approximately D/2.
1.6.2 P osttranslational m odifications
Proline incorporated into the Y position of the Gly-X-Y triplets of newly 
forming a  chains can be enzymatically converted to 4-hydroxyproHne. The 
enzyme involved in this reaction is prolyl hydroxylase which acts in the 
presence of molecular oxygen and the cofactors ascorbic acid and ferrous 
iron.
Lysine incorporated into the coUagen chains can undergo several enzymatic 
conversions. Lysine residues in the Y position of Gly-X-Y triplets can be 
converted to hydroxylysine by the enzyme lysyl hydroxylase in the presence 
of molecular oxygen and the cofactors ascorbic acid and ferrous iron. 
Hydroxylysine can undergo further posttranslational enzymatic 
modifications including glycosylation which results in the glycosylated 
derivatives galactosylhydroxylysine and glucosylgalactosylhydroxylysine.
The best understood modification of lysine and hydroxylysine is the 
conversion to their respective aldehyde forms, aUysine and hydroxy ally sine. 
These chemically active compounds are necessary for the process of 
intramolecular and intermolecular cross-Hnk formation [Tanzei, 1973] (see 
further in section 1.9).
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F ig u re  1.6 Staggered packing arrangement of molecules in the fibril sug­
gested by Hodge and Petruska (1963). (a) Electron micrographie representa­
tion of a negatively-stained collagen fibril (b) Top - diagrammatic represen­
tation of a single collagen molecule, Bottom - illustration of the axial stagger 
between molecules that produces the D-period seen in (a). ‘0 ’ - overlap 
region, ‘g’ - gap region (c) Cross-section at overlap region showing the 5 
molecules of the 5-stranded helical model
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1.7 Collagen types
Type I collagen is the major fibril-forming coUagen of the corneal stroma; it 
forms 52% of the corneal dry weight and consists of three polypeptide 
chains (each of Mr 100,000 kDa) arranged in a triple heUx. Two different 
polypeptides are found to form type I coUagen, 0:1(1) and o:2(I). A molecule 
of type I coUagen typicaUy consists of one o2(I) and two a l( I )  chains [Piez 
et al., 1963]. Type I coUagen is also found in bone, tendon and skin.
Type III coUagen is molecularly simUar to type I coUagen and is composed 
of three identical a l(III)  chains of Mr 100,000 kDa. It is found in the 
human corneal stroma (1% of the corneal dry weight) and has been shown 
to exist often in association with type I coUagen molecules [Henkel and 
GlanviUe, 1982]. It is also present in skin, blood vessels and smooth muscle. 
Type IV coUagen has been found in the corneal basal lamina and 
Descemet’s membrane [Pirie, 1951] and comprises about 1% of the corneal 
dry weight. It appears to be formed from two different kinds of polypeptide 
chain, a l(IV ) (Mr 180,000 kDa) and a2(IV) (Mr 165,000 kDa).
Type V coUagen is very similar to type I and forms about 8% of corneal 
coUagen. It is often found in association with type I fibres in the corneal 
stroma. It is possible for types I and V to be present within the same fibre 
[Linsenmayer et al., 1986] and, depending on their distribution within the 
fibre, they may affect the tensUe strength of the fibre.
Type VI coUagen has been estimated to comprise approximately 30% of the 
total corneal coUagen suggesting that it plays a very important role within 
the corneal stroma. Type VI coUagen is a hybrid molecule of part triple 
heUx and part globular protein, and rotary shadowing pictures of tliis 
coUagen type show the molecules as dumbeU-shaped with two globular 
domains of approximately equal size Unked by a long triple heHcal section. 
Although the function of type VI coUagen is relatively unknown, it may 
serve as an attachment site for ceUs and may also act between coUagenous 
and globular proteins thereby contributing to the organisation of stromal 
type I coUagen fibrils and proteoglycans [Trueb and Bornstein, 1984].
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1.8 Proteoglycans in the cornea
Proteoglycans make up the ground substance (matrix) between the cells 
and collagen of the cornea and sclera and are structurally very important. 
Essentially they consist of a core protein to which are covalently linked a 
number of repeating disaccharide units known as glycosaminoglycans 
(GAGS). These repeating units are polyanionic as a result of the presence 
of many carboxyl and sulphate groups. The disaccharide typicaUy consists 
of a hexosamine (either D-glucosamine or D-galactosamine) and a uronic 
acid (either D-glucuronic acid or L-iduronic acid). G AGs are Unked 
covalently to proteins to form proteoglycans and thereby create subunits 
that can form large proteoglycan aggregates. Under physiological 
conditions, the carboxyl and sulphate groups on the sugars are ionised, 
thereby producing highly negatively charged molecules. This feature 
contributes to the function of the proteoglycans in connective tissues since 
it produces highly hydrated, space-fiUing molecules.
In the cornea, chondroitin sulphate exists as a hybrid molecule of 
chondroitin-4-sulphate and a smaU proportion of dermatan sulphate , it is 
therefore referred to as DS/CS [Scott, 1988]. The bulk of GAG in the 
corneal stroma is keratan sulphate (KS, approximately 65%). The KS 
proteoglycan is often referred to eis lumican [KjeUen and Lindahl, 1991] and 
can exist in two forms. Although both forms have only one keratan 
sulphate side chain, the length of this chain varies and serves to distinguish 
the two types. The remainder of GAG (approximately 30%) is DS/CS. 
There are two types of DS/CS proteoglycan - they contain one and two 
DS/CS GAG chains and are referred to as ‘decorin’ and ‘biglycan’ 
respectively [KjeUen and Lindahl, 1991]. Bor cher ding et al and others 
found that coUagen fibres within the cornea appear to be covered with a 
dense coat of granules i.e. smaU highly charged KS molecules. It has been 
suggested that this coat prevents association between individual fibres 
hence it is Ukely that KS plays an important role in the spacing of coUagen 
fibres by mutual repulsion of the charged KS molecules.
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Human sclera contains predominantly dermatan sulphate proteoglycan, 
both a large and smaU type. The latter is similar to that found in cornea. 
Chick sclera has been shown to possess the DS/CS proteoglycan known as 
decorin (Mr 43 000 kDa) and à second larger proteoglycan known as 
aggrecan (Mr > 1 x 10® kDa).
Chondroitin sulphate proteoglycan (aggregan) plays an important role, as 
in cartilage, in endowing the sclera with compressive stiffness and the 
ability to sustain loading resulting from the intraocular pressure. Decorin is 
localised at specific sites along coUagen fibrils in vivo [Scott, 1988] and it is 
the core protein that is essential for binding to coUagen. In cornea KSPG 
preferentiaUy localises on the coUagen surface near the ‘a’ and ‘c’ bands 
whUe DS/CSPG preferentiaUy localises near the ‘d ’ and ‘e’ bands [Scott, 
1988] as iUustrated in Figure 1.7.
Approximately 12% of the stromal proteoglycans are in an ordered 
arrangement associated with the specific binding sites shown in the diagram 
[Meek et al., 1986]. The remaining proteoglycans seem to be distributed 
diffusely throughout the interfibriUar space.
1.9 Collagen cross-linking
Covalent cross-Hnking based on aldehyde formation from lysine or 
hydroxylysine side chains, begins between adjacent molecules. The 
intermolecular cross-Hnks stabiUse molecular arrangement within coUagen 
fibrils and, in this way, confer their stabiHty and their physical and 
mechanical properties to connective tissues. These cross-Hnks are essential 
to give fibrils the necessary tensUe strength to perform their structural role.
1.9.1 E nzym ically-derived cross-links
Lysyl oxidase is the only known enzyme involved in the cross-Hnking of 
coUagen. It contains both a copper ion and an aromatic carbonyl as 
cofactors. The enzyme initiates the formation of cross-Hnks in the
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F igu re  1.7 Diagrammatic representation of proteoglycaji binding sites 
within the D period of type I collagen (from rabbit cornea). The a-e banding 
pattern is shown in the lower portion of the diagram against the arrangement 
of collagen molecules in quarter stagger. The locations of the proteoglycans 
in the upper part of the diagram correspond to the a,c,d and e banding 
patterns (from Biochemistry of the Eye, 1991)
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extracellular space by catalysing the oxidative deamination of e-amino 
groups of specific lysyl and hydroxylysyl residues to the corresponding 
aldehydes (allysine and hydroxyallysine respectively) according to the 
following reaction:
R -C B 2-N S2 "h O2 -|- H 2 O  R-CHO -|- NH3 +  H2O -|- H2O2
These side-chain aldehyde groups spontaneously condense with e-amino 
groups of other lysyl or hydroxylysyl residues. In addition to the 
lysine-derived cross-Hnks, another covalent cross-Hnk arising from 
disulphide bonding exists in some coUagens.
Within the group of intermolecular cross-Hnks there is a subdivision, 
namely, cross-Hnks laid down in newly formed coUagen and those formed 
during maturation. The cross-Hnks of young tissue are also known as 
‘reducible’ cross-Hnks as a result of their abUity to be reduced by 
borohydride (e.g. hydroxylysinohydroxynorleucine, hydroxylysinonorleucine 
and lysinonorleucine) whereas those of mature tissue cannot be reduced 
and appear to be stable to high temperatures and low pH treatment. Hence 
they are referred to as ‘m ature’ cross-Hnks, e.g. pyridinoHne (iUustrated in 
Figure 1.8) which is also known to accumulate with age [Moriguchi and 
Fujimoto, 1978].
1.9.2 Glycation-derived  cross-links
CoUagen also conteiins nonenzymicaUy glycosylated lysine and 
hydroxylysine residues [Eyre et al., 1984] resulting from the spontaneous 
reaction of a reducing sugar, commonly glucose, with any free amino group 
available on the protein. This reaction is also known as glycation. The 
sugar-induced cross-Hnking is thought to occur possibly between the triple 
lieHces i.e. inter-triple-heHcal cross-Hnks [Bailey and Kent, 1989] as 
suggested by Figure 1.9.
Gly cation forms the first step of a reaction first shown to occur in food, the 
MaiUard reaction. This proceeds in three steps which can be subdivided
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F ig u re  1.9 Cross-Hnking of collagen suggested by Bailey and Kent (1989)
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into an initiation, propagation and termination phase (Figure 1.10).
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F igure  1.10 General scheme of the MaiUard reaction - the initial step is 
referred to as glycation (or nonenzymic glycosylation)
In itia tio n  - The reaction is initiated by nonenzymic condensation of a 
reducing sugar with an amine resulting in the formation of an Amadori 
product (AP). This is the product that many chemical assays for glycation 
measure to determine ‘am ount’ of protein glycation. The initiation step 
itself is generaUy referred to as glycation however, terms such aa glucation, 
fructation and ribation are also used to indicate the attachment of specific 
sugars like glucose, fructose and ribose respectively. The Amadori product 
can then either undergo oxidative fragmentation to irreversibly produce
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carboxymethyllysine (CML) or it may dissociate to regenerate the intact 
amine (R-NHj) while the sugar undergoes dehydration to form 1-, 3- or 
4-deoxysones. Only 3-deoxyglucosone has actually been found in vivo and 
the literature suggests that a protein-bound carbonyl is also produced as a 
post-Amadori product [Liggins and Furth, 1993].
P ro p a g a tio n  - The dicarbonyl compounds formed axe highly reactive cind 
can propagate the MaiUard reaction and induce irreversible molecular 
damage by forming heterocycUc protein adducts which have been suggested 
as both intra- and intermolecular cross-Hnks [Kato et al., 1989].
T erm in a tio n  - The protein adducts that are formed are 
thermodynamicaUy-stable and can thereby terminate the MaiUard reaction. 
GeneraUy, they are referred to as advanced glycation end-products (AGEs) 
and their structures in proteins are by and large unknown.
The rate of glycation and in turn the level of protein modification, depends 
on:
1. the sugar involved
2. the concentration of the sugar and the percentage in the open-chain form
3. the duration of exposure to sugar
4. the temperature and nature of the incubation medium
5. the half-Hfe of the protein involved
1.9.3 G lycating agents
Although glucose is the most abundant sugar in the Hving tissue, it has a 
low reactivity. Sugar phosphates (e.g. glucose-6-phosphate, 
fructose-6-phosphate) and carbohydrates with short carbon chains (e.g. 
ribose) have a higher reactivity.
In vitro studies show that fructose is a more potent glycating agent than 
glucose [Bunn and Higgins, 1981] and is as much as ten-fold more efficient
at forming AGEs [Raza and Harding, 1991]. Although there is no simple
assay for quantifying AGEs, the potential dangers of hyperglycaemia can be
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assessed by analyzing for the glucose AP (which is commonly a ketone). 
The fructose AP of any protein is an aldehyde (Figure 1.11) and it is likely 
that an assay such as the thiobarbituric acid assay may underestimate the . 
extent of fructation and ribation, i.e. reaction of a protein with fructose 
and ribose respectively. These sugars can however be used to accelerate the 
. rate of glycation when performing in vitro studies in order to speed up the 
production of AGEs under in vitro conditions.
CH— CHO 
I I
C = 0  H - C - N H - P r
I I
HO—C -H  H O -C -H
I I
H -C -O H  H -C -O H
I I
H - C -O H  H -C -O H
CHjOH CHjOH
G-AP F-AP
F igure 1.11 The structures of the glucose and fructose Amadori products 
(G-AP and F-AP, respectively). Pr represents the rest of the protein molecule
Since a greater proportion of ribose exists in the open chain form in 
solution when compared to glucose and fructose, it can react more readily 
with a protein containing sites available for this reaction. When compared 
to glucose, fructose contains a greater quantity of the open chain form in 
solution. In addition, glucose has a stable ring structure as a result of the 
equatorial orientation of its hydroxyl groups. This stable ring structure 
greatly retards the rate at which glucose reacts with protein molecules. The 
significance of such stabiHty means that high concentrations of glucose, a 
major metaboHc fuel, and proteins can co-exist in various tissues.
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1.9.4 Fate o f g lycated  proteins
Following glycation, a long-lived protein sucli as collagen may take several 
routes as illustrated in Figure 1.12. It can be converted to the SchiiF base 
which can dissociate to give free protein; it may be catabolised to produce 
amino acids; it can be oxidised to produce reactive compounds such as 
3-deoxyglucosone; or the protein can undergo further reactions which 
include oxidative reactions forming AGEs.
PENTOSIDINEProtein
3D0G
AP Non-fiuorescent cross-linksProtein
CML, CMhL
Turnover
aa
F igure  1.12 The various pathways that a glycated protein can take. 3-DOG, 
3-deoxyglucosone; aa, amino acid; CML, carboxymethyllysine; CMhL, car- 
boxyme t hylhy droxy lysine ; [0], oxidative reaction
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1.10 A dvanced glycation end-products 
(A G Es)
The AP (Amadori product) resulting from the glycation of a protein may 
react with other APs or free amino groups on this protein or a different 
protein. The result is the slow formation of AGEs. Since coUagen is a 
long-lived protein these products are able to accumulate in vivo such that 
they can induce irreversible damage to the protein and can also be detected 
as weU as quantified. Such structures are not yet fuUy characterised and 
little is known of their properties. Although the glycation-derived cross-link 
pentosidine has fluorescent properties, the majority of glycation-derived 
products are likely to be non-fluorescent.
AGEs have been difficult to characterise since they appear to be
1) relatively complex ,
2) susceptible to destruction during acid hydrolysis
3) produced in low yields
4) difficult to isolate since artefacts may be generated during isolation 
procedures.
Three types of AGE have been identified one of which is discussed below 
since, from the studies carried out in this thesis, a simUar structure may 
well exist in human cornea and sclera.
1.10.1 P entosid ine
This fluorescent cross-link, was first isolated from human dura mater 
collagen in 1989 and has been characterised by Sell and Monnier. The 
concentration of the cross-Hnk was found to increase with tissue age and 
was present in noticeably higher concentrations within diabetic tissues [Sell 
and Monnier, 1990]. Trace amounts of pentosidine have also been found in 
human skin collagen and lens protein where its concentrations have also 
increased with age [Dyer et al., 1991].
Pentosidine, illustrated in Figure 1.13, is a cross-linking structure resulting
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from the condensation of an arginine residue, a lysine residue and a 
pentose. It has been found to exist in tissues particularly exhibiting a high 
metabolic rate, reflecting high levels of pentose turnover. Pentosidine 
formation has been observed during nonenzymatic browning of proteins by
glucose [Dyer et al., 1991].
CHCOOH
CH.
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F ig u re  1.13 The structure of the proposed cross-Unking structure pentosi­
dine
1.11 P hysiological consequences o f
glycation  on the ageing o f collagen
f
The formation of the SB and the AP can result in an alteration of the 
isoelectric point of the protein and any changes in charge will lead to 
conformational changes of the coUagen molecule. Though some 
investigators [Trueb, 1984] doubt if the low levels of glycation products 
found in vivo could result in significant physical changes in coUagenS, others 
point out tha t glycation could take place at biologically im portant sites on 
the molecule, for example the coUagenase site or glycoprotein-interacting
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sites [Bailey et al., 1989].
Glomerular basement membrane contains type IV collagen and in vitro 
glycation of this, has been shown to affect the flexibility of the membrane 
and the permeability of the capillaries [GarHck et al., 1988]. Binding of 
flbronectin and heparan sulphate to bcisement membrane coUagens is crucial 
in filtïation and it has been reported that there is a reduction in the aiBnity 
of proteins to in vitro glycated type IV basement membrane coUagen [Tarsio 
et al., 1987]. Glycation of the main coUagenous domain NCI (located at the 
carboxyl end of type IV coUagen molecules) may weU interfere with normal 
assembly of type IV coUagen in diabetes meUitus and is possibly related to 
abnormal basement membrane function in this condition.
In vitro glycation of coUagen has been shown by many workers (Yue et al., 
1983; Brownlee et al., 1986; Tanaka et al., 1988) to alter its stabiHty, 
solubUity and digestibUity by enzymes. Although earher work reported an 
increase in the in vivo glycation of skin, basement membrane and tendon 
coUagen with age, recent studies reveal only sUght increases with tissue age 
[Patrick et al., 1990]. It has been suggested however, that the discrepancies 
between the results may weU be due to differences in the methods used to 
assay for glycation.
The alterations in coUagen cross-Hnking, rigidity, browning, fluorescence 
and a reduced susceptibiHty to proteolysis have been used as markers for 
AGEs and have been shown to increase in diabetes [Monnier et al., 1986].
It has yet to be determined whether such changes are due solely to 
glycation-induced AGEs or whether free radicals play a role [Jones et al., 
1986].
1.12 Inhibition o f glycation and AGE  
form ation
The reactions that result in the formation of AGEs have been found to 
require oxygen and trace metal ions [Fu et al., 1992]. Metal ion chelators
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can therefore inhibit these reactions as can antioxidants. Although, within 
the body, there may exist natural mechanisms to protect against such 
protein damage,, at present there is considerable interest in pharmacological 
compounds (particularly aspirin) which may reduce or prevent glycation 
and AGE formation in vivo.
1.13 X-ray diffraction
The technique of X-ray diffraction can be employed to investigate 
regularly-arranged tissue structures such as collagen molecules and collagen 
fibrils within the cornea. It is the regularity of such structures that allows a 
characteristic X-ray diffraction pattern to be obtained. Using this highly 
sensitive technique it is possible to calculate the mean coUagen interfibriUar 
spacing and also the mean intermolecular spacing.
The great advantage of this specialised technique is that the corneal and 
scleral tissues can be examined as close to their natural states as possible 
since there is no requirement for processing as in electron microscopy. The 
only tissue preparation involved is that of setting the corneal and scleral 
hydrations as close as possible to their physiological values prior to 
exposure to the X-ray beam. Again, in contrast to electron microscopy, the 
pattern arising from exposure of the specimen to the X-ray beam is 
automaticaUy averaged for the dimensions of that beam. Electron 
micrographs of tissue sections exhibit areas of varied structure hence the 
interpretation can be more difficult than with X-ray patterns.
1.13.1 Equatorial and m eridional diffraction  
patterns
A typical X-ray diffraction pattern from human cornea using a wide-angle 
camera is shown in Figure 1.14 along with the pattern obtained from a 
human cornea using a low-angle camera.
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bF igure 1 .14  Typical X-ray diffraction patterns from the human cornea, (a) 
The high angle pattern from human cornea. The first order reflection derived 
from the intermolecular spacing is indicated by an arrow and corresponds to a 
spacing of approximately 1.80 nm, the outer ring (m) derives from the mylar 
window of the X-ray cell, (b) The low angle pattern from human cornea. 
The flrst order equatorial reflection, indicated by an arrow, is derived from 
the approximately 57 nm interfibriUar spacing
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Figure 1.14(a) shows that the high angle equatorial diffraction pattern of 
cornea is a diffuse ring (low exposure). This arises from the lateral packing 
of the collagen molecules within the fibrils. Figure 1.14(b) shows that the 
low angle equatorial diffraction pattern (again at low exposure) consists of 
a single reflection. The pattern arises from regularity in the side-to- side 
packing of the uniform collagen fibrils [Goodfellow, 1975]. In bovine cornea, 
the pattern is circular which implies that the coUagen fibrils are orientated  
in approximately equal numbers in aU directions in the plane of the cornea. 
On further inspection of the pattern it is found to contain four lobes, these 
suggest that the fibrils are preferentiaUy orientated in a superior-inferior 
manner. The width of the ring is related to the range of interfibriUar 
spacings present and hence the mode of packing of the fibrUs within the 
cornea.
It is not possible to obtain X-ray reflections from the interfibriUar spacing 
in sclera since the coUagen fibrils within this tissue vary greatly in size.
1.14 A im s  and objectives  o f  this thesis
Changes in the structural organisation of the coUagen within the cornea 
and sclera can affect both the physical and optical properties of these 
tissues. In an attem pt to investigate the causes of such changes, age-related 
studies were performed on both human corneas and scleras and also on the 
incubation medium in which they are housed. The aims of this work have 
been to investigate :
1) using SDS-PAGE and electron microscopy, the possible leaching 
(age-related or time-related) of proteins/proteoglycans from the 
corneoscleral discs to the incubation medium housing them
2) using X ray diffraction, the age-related changes in both the fibriUar and 
molecular organisation of type I coUagen in the human cornea and sclera
3) using biochemical assay, the occurrence of non-enzymic glycosylation  
(glycation) within corneal and scleral coUagen and the changes with tissue 
age
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4) using biochemical assay, the occurrence of AGEs in both tissues and any 
alterations in their levels with tissue age
5) using a combination of biochemical techniques and X-ray diffraction, the 
ability to reproduce the results obtained by using in vitro set-ups (i.e. 
inducing glycation and then observing the effect on the molecular 
parameters)
6) the susceptibiHty of different coUagen types to sugar-induced 
modifications
7) the effects of various inhibiting compounds on the level of glycation and 
the formation of AGEs in vitro
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Chapter 2
M aterials and M ethods
The chemicals and materials used in the investigations are Hsted below 
together with their suppHers.
X-ray diffraction
X-ray film
PEG (mwt 20,000)
Caeverken, Strangnass, Sweden 
BDH Laboratory Supplies, Poole, U.K.
14 kDa cut-off dialysis tubing Medicell International Ltd, London, U.K.
H ydroxyproH ne assay 
Hydrolysis tubes
HydroxyproHne 
Perchloric acid 
Chloraniine T 
2- Methoxyethanol 
Citric acid monohydrate 
Glacial acetic acid 
Sodium acetate trihydrate 
p-Dimethylaminobenzaldehyde
Sarstedt SuppHers, Leicester, U.K.
Sigma Chemical Co. Ltd, Dorset, U.K. 
Sigma Chemical Co. Ltd, Dorset, U.K. 
BDH Laboratory SuppHes, Poole, U.K. 
Aldrich Chemical Co. Ltd, Dorset, U.K. 
BDH Ltd, Poole, U.K.
BDH Ltd, Poole, U.K.
BDH Ltd, Poole, U.K.
Aldrich Chemical Co. Ltd, Dorset, U.K.
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Thiobarbituric acid (T B A ) assay
Oxalic acid BDH Ltd, Poole, U.K.
2-TBA Sigma Chemical Co. Ltd, Dorset, U.K.
TCA BDH Ltd, Poole, U.K.
Polyacrylam ide gel electrophoresis
Acrylamide
N ,N ’ ,methylenebisacrylamide 
TEMED
Ammonium persulphate
/?-mercaptoethanol
SDS
Tris buffer
Molecular weight markers 
Coomassie blue 
Alcian blue 8GX
Photographic film (Ilford Pan F ISO 50)
BDH Ltd, Poole, U.K.
BDH Ltd, Poole, U.K.
BDH Ltd, Poole, U.K.
BDH Ltdi Poole, U.K.
Sigma Chemical Co. Ltd, Dorset, U.K. 
BDH Ltd, Poole, U.K.
Sigma Chemical Co. Ltd, Dorset, U.K.
Sigma Chemical Co. Ltd, Dorset, U.K.
Sigma Chemical Co. Ltd, Dorset, U.K.
Sigma Chemical Co. Ltd, Dorset, U.K.
Ilford Ltd, Mobberley, Cheshire, U.K.
G lycosam inoglycan assay  
Alcian blue
Chondroitin sulphate
Sigma Chemical Co. Ltd, Dorset, U.K. 
Sigma Chemical Co. Ltd, Dorset, U.K.
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Electron m icroscopy
Agar 100 resin Agar Scientific Ltd, Essex, U.K.
DDSA Agar Scientific Ltd, Essex, U.K.
MNA Agar Scientific Ltd, Essex, UiK.
BDMA Agar Scientific Ltd, Essex, U.K.
Cuprolinic blue stain BDH Ltd, Poole, U.K.
In vitro glycation
Collagen type I from calf skin
Collagen type I from bovine achilles tendon 
CoUagen type IV from human placenta 
CoUagen type I from rat taU
AU coUagen types suppUed by Sigma Chemical Co. Ltd, Dorset, U.K.
Enzym es
Papain (Papainase; EC 3.4.22.2) Sigma Chemical Co. Ltd, Dorset, U.K. 
CoUagenase (EC 3.4.24.8) Sigma Chemical Co. Ltd, Dorset, U.K.
Other chemicals
Aminoguanidine Sigma Chemical Co. Ltd, Dorset, U.K.
AcetylsalicyUc acid Sigma Chemical Co Ltd, Dorset, U.K.
Diethylenetriaminepentaacetic acid Sigma Chemical Co Ltd, Dorset, U.K.
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2.1 Corneal supply and storage
The cultured human corneas and scleras were obtained from the Corneal 
Transplant Service Eye Bank, U.K. They were received as corneoscleral 
discs and stored at 34° C in an incubation medium comprised essentially of 
Eagles MEM with Earle’s salts and HEPES buffer, 2% foetal calf serum, 
2mM L-glutamine, 24mM sodium bicarbonate, 100 units ml“  ^ penicillin, 
O.lmg ml“  ^ streptomycin and 0.25/tg ml~^ amphotericin B [Armitage and 
Moss, 1990]. These corneas were assumed to represent ‘normal’ individuals, 
unless the cHnical details indicated otherwise, and had been rejected by the 
Eye Bank as unsuitable for grafting because of low endotheHal cell counts 
and/or large arcii. The scleral rim was separated from the corneal disc 
using a metallic cork borer. The epithehal and endotheHal ceU layers were 
then removed by gently scraping with a scalpel blade. The tissues were 
tightly wrapped in cHng film to minimise changes in hydration and stored 
at -40° C until used for investigation. The incubation media were also stored 
frozen for future analyses.
2.2 X-ray diffraction
Both high and low angle X-ray diffraction patterns for human corneas and 
scleras were recorded at the SERC high intensity synchrotron source at 
Daresbury, U.K. Since structural pgirameters such as interfibriUar and 
intermolecular spacings are strongly dependent on tissue hydration, before 
X-ray measurements were made, the corneal and scleral hydrations were set 
by placing the corneal discs into 14 kDa cut-off dialysis tubing and 
immersing them in a solution of 1.5% PEG containing 0.15M sodium 
cliloride (for human corneas) or 2% PEG containing 0.15M sodium chloride 
(for human sclera). EquiHbration was carried out for 4 days at 4°C.
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The tissues were then brought to room temperature, removed from the 
dialysis tubing, weighed and placed in air-tight cells. The specimens were 
examined by passing the X-ray beam through the central region of the 
corneal button. Data were obtained on the interfibriUar spacing and the 
intermolecular spacing of the same specimens (however, for scleral tissue 
only an intermolecular measurement was possible).
High angle diffraction
High angle diffraction was carried out at station 7.2b. The 
wavelength of the X-rays was 0.1488nm ctnd the beam was collimated 
to a diameter of 0.5mm. Exposure times of 3-4 minutes were used 
and the specimen-to-film distance was approximately 12cm. The 
camera was calibrated using the 0.305nm lattice reflection of 
calcite. Measurement of the first order diffraction ring from the 
packing of the collagen molecules allows the first order Bragg 
spacing to be obtained. The Bragg spacings were increased by a 
factor of 1.11 to obtain the mean centre-to-centre intermolecular 
spacing in the cornea; this factor relates to the ‘pseudo- 
hexagonal’ packing reportedly present in collagen fibrils 
[Maroudas et al., 1991].
Lowr angle diffraction
Low angle diffraction was carried out at station 8.2. The 
wavelength of the X-rays was 0.154nm and the beam dimensions were 
4mm X 0.5mm (focussed in the vertical direction). Exposure times 
of 2 minutes were used and the specimen-to-film distance waa 
approximately 3m. The camera was calibrated using the 67nm axial 
periodicity of rat tail tendon. Measurement of the first order 
diffraction ring from the packing of the collagen fibrils within 
the corneal stroma eiUows the first order Bragg spacing to be 
obtained. The Bragg spacing is increased by a factor of 1.12 to 
give the mean centre-to-centre spacing of the collagen fibrils.
This factor arises from the most probable packing arrangement 
present in the comeal stroma [Worthington and Inouye, 1985].
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After exposure the tissues were re-weighed to ensure that their hydration 
had remained fairly constant. Diffraction patterns were recorded on 
Caeverken AB photographic film.
The tissue hydration (H) was calculated following X-ray diffraction using 
the formula :
^  w e t  w e i g h t  — d r y  w e i g h t  
d r y  w e i g h t
2.2.1 X-ray pattern  analysis
The X-ray patterns obtained for each tissue were digitised using an 
Ultrascan XL Laser Microdensitometer (LKB Instruments, Gaithersburg, 
MD) which produced hnear scans across the diffraction rings.
Measurements were made after taking account of local background scatter. 
A typical densitometer scan of the X-ray diffraction pattern from a 
middle-aged human cornea in a wide angle camera is illustrated in 
Figure 2.1.
Interpretation of the X-ray patterns involves use of Bragg’s equation :
n X  =  2 d s i n d
where n is the order of the reflection, A is the wavelength of the radiation, 0  
is half the angle of scatter, d  is the Bragg spacing, and n is the order of the 
reflection. As mentioned earlier, the specimen-to-film distance (SFD) can 
be accurately obtained by using a calibration specimen of known spacing - 
calcite (d=0.305nm) for the high angle studies and rat tail tendon 
(d—67nm) for the low angle ones. For the calibration specimen A and d  are 
known, therefore by using Bragg’s equation (for n  =1) it is possible to 
obtain 9.  The SFD can be calculated by measuring the radius of the X-ray 
pattern. Once the SFD is known, it is possible to calculate 9 by measuring 
the diameter of X-ray patterns from human specimens, this allows d  the 
Bragg spacing to be obtained for all specimens.
45
I K E c  LJ 1  t  C 3 S c  a n  X I_
Run by  O p e r a t o r  : # 1 Run ID # = 1
T ra c k  = 1 o f  1 X - p o s i t i o n  = 1 2 6 .6
T ype o f  beam  = l i n e  S m o o th in g :  YES
X-wi d t h  = 2
NO i n t e g r a t i o n
Absorbance A-axis: is normalized ( A-min = 0.19 A-mas = 2.00 )
T
n
1st subsidiary reflection
V
\
\
\
60
Y-position (mm)
70 80 90
 > Y-start = 2S Y-stop = 100 Y-step = I
F ig u re  2.1 Densitometer scan produced from analysis of an X-ray diffraction 
pattern of a middle-aged human cornea
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2.3 Extraction o f corneal and scleral 
collagen
Several extraction steps were required to isolate collagen from the cultured 
corneas and scleras prior to biochemical measurement of glycation and 
fluorescence. The procedure below would be expected to isolate 
predominantly type I collagen.
Extraction in 0.15M sodium chloride for 3 days at 4°C removed soluble 
material from the tissue and this was followed by extraction in a 4M 
guanidine hydrochloride/0.15M sodium chloride mixture for 3 days which 
removed more strongly bound materials such as proteoglycans [Wcdl, 1990]. 
Several washes in 0.15M sodium chloride were required to remove any 
traces of guanidine hydrochloride. Throughout the entire washing 
procedure the tissues remained at 4°C and the solutions were constantly 
stirred. Protease inhibitors - 2 .5mM benzamidine hydrochloride, 0.01% 
trypsin inhibitor and 5mM disodium EDTA - were added to all the 
extraction solutions. The collagen from the tissues was solubilised by 
digesting with papain (0.5mg ml“  ^ citrate buffer pH 6) at 45-50° C for 24 
hr s. Once digested, the samples were centrifuged at 9000rpm for 10 mins 
and the supernatant was stored frozen for biochemical analysis.
2.3.1 D igestion  o f collagen
Dialysed corneal and scleral tissue samples were subjected to several 
extractions (described in section 2.3) in order to remove proteoglycans such 
that type I collagen predominantly remained. The collagen obtained was 
then digested with papain (0.5mg/ml citrate buffer, pH 6). The various 
different collagen types obtained from the manufacturer were digested with 
coUagenase (200IU in 0.05M phosphate buffer, pH 7.4) since this enzyme is 
more specific for collagen than is papain. AU digestions were carried out at 
37°C for 48 hrs. FoUowing digestion, the samples were centrifuged for 10 
mins at 9000rpm and the supernatant coUected and stored frozen at -40° C
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until required for assay.
2.4 Polyacrylam ide gel electrophoresis
For the sepeiration of corneal components that may have leached from the . 
tissues into the storage medium, SDS-discontinuous polyacrylamide gel 
electrophoresis was performed according to the method of Laemmh (1970). 
Two types of study were performed to investigate firstly, any change in the 
amount of component leaching from the tissue into the medium as a 
function of tissue age and secondly, the amount of leaching as a function of 
period of storage of a tissue of known age in the incubation medium.
2.4.1 Sam ple preparation
Prior to electrophoresis 100/xl volumes of each sample (study 1: volumes of 
incubation medium taken from storage of corneas of various ages, study 2 
volumes of incubation medium taken from storage of particular corneas 
after 1 and 3 weeks in the same incubation medium) were heated in the 
presence of an excess of SDS and /3-mercaptoethanol to ensure protein 
dénaturation. Assuming that the resultant polypeptides bound SDS such 
that they possessed identical charge densities, migration in the 
polyacrylamide gels wiU have occurred according to polypeptide size (M,.). 
The SDS and mercaptoethanol were components of a sample buffer which 
consisted of 0.125M Tris (pH 6.75) conteiining 20% glycerol, 4% SDS, 10% 
/^-mercaptoethanol and 0.002% bromophenol blue. This buffer was added 
to an equal volume of sample (i.e. 100/zl) which was incubated for 5 mins at 
100° C in a Techne Dri-block to dissociate the proteins by allowing the 
/^-mercaptoethanol to reduce disulphide bonds.
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2.4.2 Polyacrylam ide gel preparation and running
Gels q£ dimensions 14 x 18cm and 1.5mm thickness were cast using an LKB 
2001 vertical slab gel electrophoresis cell. Heated sample volumes of 5 0 f i l  
were loaded into preformed sample wells in the stacking gel. A 
discontinuous buffer system was prepared by polymerization of the 
resolving gel followed by polymerization of the stacking gel on top of this. 
The gels were generally run in pairs with an applied voltage of 150V 
(current 110mA) for approximately 5 hrs. In each case a 7.5% acrylamide 
gel was prepared for use as follows.
R esolv ing  gel
7.5% acrylamide 
0.2% bis-acrylamide 
0.375M Tris-HCl pH 8.8 
0.1% SDS
0.075% ammonium persulphate 
3 3 f i l  TEMED/lOOml resolving gel
Stacking gel
3.5% acrylamide 
0.1% bis-acrylamide 
0.125M Tris-HCl pH 6.8 
0.1% SDS
0.075% ammonium persulphate 
75^1 TEMED/lOOml stacking gel
Molecular weight markers were run alongside the samples and contained 
the following proteins:
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M W  m ark e rs M ,
Myosin 205,000
^-Gailactosidase 116,000
Phosphorylase B 97,400
Albumin (bovine) 66,000
Albumin (egg) 45,000
Carbonic anhydrase 29,000
Following electrophoresis, the gels were carefully removed from the glass 
plates and fixed in a 10% TCA solution overnight and then stained for 
either protein or carbohydrate.
2.4.3 Staining o f polyacrylam ide gels 
C oom assie blue protein stain
After fixing in TCA overnight, the gels were carefully placed in a solution 
of 0.125%(w/v) Coomassie blue in 10%(v/v) acetic acid/45%(v/v) 
methanol for approximately 5 hrs. The gels were then destained in several 
changes of 5%(v/v) methanol/7%(v/v) acetic acid until a clear background 
was obtained.
Alcian blue staining of glycosam inoglycans
The gels were fixed in 50%(v/v) methanol/7%(v/v) acetic acid for 1 hr and 
washed in distilled water for a further hour, these two steps were repeated 
since it was im portant to remove completely the SDS prior to gel staining. 
After washing, the gels were stained in a solution of 0.2%(w/v) Alcian 
blue/3%(v/v) acetic acid/0.2M MgClg overnight. Following this, destaining 
in several changes of 3%(v/v) acetic acid/0.05M MgCl] was carried out 
until the gel background was clear. MgClg was included in the staining and
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destaining solutions to increase the specificity of staining and reduce 
background staining [Wall and Gyi, 1988].
The gels were photographed using Ilford Pan F ISO 50 black and white 
film. A Cannon A1 camera was used (with a Cannon FD lens 50mm) and 
Dfospeed 5 photographic paper was used for good contrast prints.
2.5 Total glycosam inoglycan assay
The glycosaminoglycan content of the tissue culture medium was analysed 
using the microdetermination dye binding assay of Bartold and Page 
(1985). This method was chosen because of its sensitivity and its 
requirement for very fit tie sample.
The assay relies upon the specificity of Alcian blue for glycosaminoglycans 
at an electrolyte concentration that minimizes the staining of other 
negatively-charged glycoproteins. Cellulose acetate electrophoresis 
membranes were marked at 2cm intervals along their length to make 
'squares. A sample volume of 20;ul (approximately 0.05-1.0mg ml“  ^ GAG) 
was applied to each square and allowed to soak into the membrane. The 
strips were immersed in a staining solution of 0.2% Alcian blue in 0.05M 
magnesium chloride, 0.025M sodium acetate in 50%v/v ethanol/water. The 
strips remained in this solution for 30 mins at room temperature and were 
then destained in 3 changes (each of 15 mins length) of the same solution 
without the Alcian blue stain. Following destaining, the strips were blotted, 
cut at the marked 2cm intervals, placed in 2ml dimethyl sulfoxide and 
vigorously mixed until dissolved (approximately 15 mins). The absorbance 
of the resultant solution was read on a Pye Unicam SP6-400 UV 
spectrophotometer at a wavelength of 678nm. The absorbances were 
compared to those of a chondroitin sulphate standard curve (Figure 2.2).
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F ig u re  2.2 Standard curve produced using chondroitin sulphate standards 
for the total glycosaminoglycan assay
52
2.6 H ydroxy proline assay
In order to quantify the hydroxyprohne content of both corneal and scleral 
collagen an assay devised by Woessner (1961) was employed. Prior to assay 
the corneal/scleral digests (0.2ml) were vortexed and acid hydrolysed with 
an equal volume of 12M hydrochloric acid in hydrolysis tubes. Hydrolysis 
W2LS performed at 110°C for 18 hrs after which the digestion mixture was 
transferred to a graduated cylinder and weished three times with distilled 
water (1ml volume each time). A few drops of lOM sodium hydroxide were 
added to adjust the pH to within the range 5-7.5. The final volume of the 
solution was adjusted to 5ml with distilled water. Standards of known 
hydroxyprohne concentration were prepared and run alongside these test 
samples using the procedure described below.
To 0.1ml of hydrolysed corneal/scleral sample was added 1ml of 0.05M 
chloramine T. The tubes were shaken and allowed to stand at room 
temperature for 20 mins. A 3.15M perchloric acid solution (1ml) was 
added, the tubes were again shaken and kept at room temperature for 5 
mins. Finally 1ml of DMBA was added to each tube and after thorough 
mixing all tubes were placed in a water bath at 60°C for a further 20 mins. 
The absorbance of each solution was read using a Pye Unicam SP6-400 
spectrophotometer at a wavelength of 557nm and the unknown 
hydroxyprohne concentrations were read off the prepared standard curve 
(Figure 2.3).
2.7 Electron m icroscopy
Transmission electron microscopy was used on human corneas that had 
been incubated in culture medium for varying periods. By using a 
Cuprohnic blue staining technique it was possible to investigate changes in 
tissue proteoglycan composition as a function of storage time.
The ‘critical electrolyte' method of Scott and Orford (1981) was employed 
to stain the proteoglycans. Small pieces of cornea (approximately Imm^)
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were stained overnight in 0.05% Cuprolinic bine in a 25mM sodium acetate 
buffer (pH 5.7) containing 2.5% glutciraldehyde and O.IM MgClg. The 
following day the samples were rinsed for three 15 min periods in the buffer 
solution containing the fixative glutaraldehyde and MgClg. The samples 
were then washed three times (15 mins each time) with 0.5% aqueous 
sodium tungstate and then three times (again 15 mins each time) with 
0.5% sodium tungstate in 50% ethanol. Following this the samples were put 
through an ethanol dehydration series and two 30 min changes in propylene 
oxide. The specimens were eventually placed in a 3:1 mixture of propylene 
oxideiAgar 100 resin overnight. The propylene oxide was allowed to 
evaporate out of the mixture since the sample bottles were left uncovered 
throughout this period. The samples were eventually placed in 100% Agar 
100 resin for 12 hrs and then polymerized at 60°C for 48 hrs.
From the embedded material silver-gold sections of approximately 70nm 
thickness were cut using a Dupont diamond knife on a Reichert-Jung 
Ultracut E ultramicrotome.
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Chapter 3
D evelopm ent o f G lycation  
Procedures
Assays for the glycation of collagen are limited as a result of the 
interference by the natural cross-hnks of collagen and enzymically-linked 
sugar (glycosylation) where the glycosidic bonds have been destroyed. The 
assays often quantify the carbonyl moiety of the glycated protein, 
commonly the SB and AP. The AP from the natural cross-links of collagen 
can affect the results of such assays unless reduced with sodium 
borohydride prior to glycation. The thiobarbituric acid assay (TEA) is a 
widely used colorimetric method for measuring protein glycation 
specifically the amount of AP. Since it is a time-consuming procedure it has 
been largely discontinued by routine laboratories but it has been used 
successfully to measure glycated collagen. Even though the TEA method 
has been superseded by other methods, it remains a simple, convenient and 
inexpensive method for assaying glycated collagen.
3.1 Thiobarbituric acid (T B A ) assay
A microplate version of the TEA method by Parker et al (1981) was 
developed here to measure relative amounts of glycation in both corneal 
and scleral collagen across the entire age range of samples and the assay
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was also used for in vitro glycation assessments. Essentially the assay works 
. by converting the sugar moiety of the glycosylated protein to 
5-hydtoxymethylfurfural (5-HMF; illustrated in Figure 3.1) by heating with 
oxalic acid. The adduct formed by reacting 2-thiobarbituric acid with 
5-HMF is measured photometrically and results are expressed as nanomoles 
of HMF or fructose equivalents. A fructose standard curve is used because 
the sugar moiety of a glucose AP has the fructose configuration, i.e. the 
carbonyl group is located on the C-2 position of the AP. The absorbance of 
the coloured adduct is proportional to the concentration of Amadori 
product in the protein. This method has the advantage that the Schiff 
bases and collagen cross-links do not interfere with the assay [Furth, 1988]. 
Mild hydrolysis of 0.1ml of sample (supernatant obtained from collagen 
digestion) with 0.1ml of 0.5M oxalic acid was performed at 124KPa, 124°C 
for 1 hr to release 5-HMF. The protein was precipitated by addition of
0.1ml 40% TCA. Following centrifugation at 10,000rpm for 10 mins, 0.2ml 
of supernatant was removed and transferred to a microplate. To the 
supernatant was added 0.067ml of 0.05M TBA (brought to pH 6 with 
NaOH). The microplate was incubated at 37°C for 35 mins after which the 
absorbance was read at 450nm on a Bio-Tek microplate autoreader.
Fructose standards were used to produce a standard curve (Figure 3.2) 
from which the 5-HMF concentration (nmols in 0.1ml of sample) could be 
read for both corneal and scleral digests. A reagent blank (0.1ml of 0.15M 
saline) was prepared and run alongside the test samples and standards. 
During this thesis, the method of Parker et al was further modified and 
adapted for use with a microplate reader. This modified version has an 
improved yield of HMF and increased sensitivity requiring only 1 mg of 
protein. Using the microplate autoreader ii is also possible to read up to 94 
samples in 40 seconds.
Free sugars do however interfere in the assay but can be readily removed by 
dialysis. It has been suggested by Schleicher et al (1981) that enzymically 
bound sugars interfere in the TBA method since any 6-carbon sugar (or 
that containing greater than 6-carbon atoms) whose AP has a carbonyl
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F ig u re  3.1 Formation of 5-hydroxymethylfurfnral (HMF) during the TBA 
assay
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group on the C-2 position, could result in ring-closure to form 5-HMF.The 
corneal and scleral proteoglycans are a source of 6-carbon sugars however, 
these are removed by prolonged extraction in guanidine hydrochloride 
(described earlier) prior to the TBA assay. Using in vitro glycated collagen 
as a model glycoprotein, the investigation performed below suggests that 
the total interference by enzymically bound sugar is <8%.
T B A  assay - Interference by glycoproteins
The in vivo formation of the reducible collagen cross-link 
dehydrodihydroxylysinonorleucine undergoes a spontaneous Amadori 
rearrangement to form hydroxylysino-5-ketonorleucine (Figure 3.3). This 
slruttuxc, an Amadori product, may well interfere in the TBA assay such 
that the TBA assay value becomes a measure of AP from both glycation of 
collagen and the formation of reducible cross-hnks in collagen with age. 
Borohydride reduction of in vitro glycated type I collagen (from bovine 
tendon) was performed by incubating with 55mM sodium borohydride in 
ImM NaOH, pH 7.4 at 37°C overnight [Olufemi et al., 1987]. The 
incubation mixture was placed on a magnetic stirrer throughout this 
period. At the same time, another aliquot of in vitro glycated type I 
coUagen (lOmg/ml) was incubated in the absence of sodium borohydride
i.e. in ImM NaOH, pH 7.4 at 37°C. The reduction was terminated by 
reducing the pH to 3.0 using concentrated acetic acid and the coUagen was 
dialysed exhaustively against water to remove any unreacted borohydride. 
Following this, both coUagen samples were centrifuged at 9000rpm for 10 
min and the precipitate of each sample was resuspended in 0.05M 
phosphate buffer, pH 7.4, containing 200 lU coUagenase and incubated at 
37°C for 48 hrs. Chloroform and toluene (5/il each) were added to prevent 
bacterial growth. After centrifugation at 9Q00rpm for 10 min, the 
supernatant for each sample was coUected and used for TBA analysis.
Type I coUagen was also extracted from human corneas and scleras (using 
approximately 5-lOmg of tissue) after removing the tissue proteoglycans. 
The extracted samples were also subjected to borohydride reduction as 
above and were digested with papain (0.5mg/ml citrate buffer, pH 6) at
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F ig u re  3.3 The formation in vivo of the reducible cross-link dehydrodihy- 
droxylysinonorleucine, its spontaneous Amadori rearrangement to form the 
keto-imine hydroxylysino-5-ketonorleucine, and its reduction in vitro to form 
dihydroxylysinonorleucine
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50-55°c  for 24 hr prior to TBA analysis.
In the absence of borohydride reduction of type I coUagen, the amount of 
HMF g enerated was 0.012 nmol/nmol hypro. FoUowing borohydride 
reduction this figure feU to 0.011 nmol/nmol hypro. This impHes that an 
interference of approximately 8% is occurring and it may be possible to use 
this procedure to correct for interference by glycoproteins.
T B A  assay - Yield of chrom ophore
Part of the investigation looked at percentage of HMF lost during the 
heating step in the autoclave method. The importance Kes in the need to 
balance the production of HMF with its destruction. Parker et al had 
reported 30% loss of HMF after 1 hr of heating in an autoclave whereas the 
microplate version, by comparing the quantity of chromophore produced by 
prepared HMF standards when mixed either directly with TBA or 
subjected to the fuU assay procedure, found only a 13% loss of HMF. The 
autoclave version of the TBA method introduced by Parker et al has the 
advantage of requiring only 1 hr of hydrolysis compared to earUer versions 
which needed between 4 and 8 hrs (Ney et al., 1981; McFarland et al.,
1979) and hence resulted in greater loss of HMF.
The in vivo glycation of human corneal and scleral coUagen as measured by 
this microplate version of the TBA assay, produced values of 9.24 -j-/- 0.235 
and 1.50 -f/- 0.245 nmol HM F/mg coUagen respectively for tissue ages 
between 20-30 years. Since human skin coUagen is known to be more 
glycated than both corneal and scleral coUagen, the results of this 
investigation compare weU with those of other workers who have employed 
the autoclave version of the TBA method - they obtained a value of 14.58 
4-/- 3.11 nmol HMF/mg coUagen for tissues aged between 20-30 years 
[Miksik and Deyl, 1991].
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3.2 Fluorescence em ission m easurem ents 
for AGEs
Structural changes in glycated proteins can be explored by measuring 
changes in fluorescence which are believed to indicate cross-linking and 
AGE formation in a variety of proteins (Sell and Monnier, 1989b; Ahmed 
and Furth, 1990). One fluorescent cross-link structure which has been 
relatively well characterised is pentosidine (described in Chapter 1). Its 
optimum wavelengths are 325nm (excitation) and 375nm (emission) and it 
is considered to be the major fluorophore in glycated model proteins [Dyer 
et al., 1991]. However, for glycated collagen the excitation-emission 
wavelengths that give maximum fluorescence are 370nm and 440nm 
respectively (Kohn et al., 1984; Monnier et al., 1986; Miksik and Deyl,
1991; Odetti et al., 1992). Even though pentosidine is found in collagen in 
vivo [Sell and Monnier, 1989], the wavelengths most sensitive to 
glycation-induced change were used here.
Fluorescence emission of the corneal and scleral digests was measured using 
an Aminco-Bowman spectrophotofluorometer (model J4-8960). 
Approximately 1ml of supernatant was required for the glass cuvettes used 
and the machine was zeroed on the appropriate enzyme blank (either 
papain or coUagenase). Most measurements were made at an excitation 
wavelength of 370nm with emission at 440nm [Kohn et al, 1984] and results 
were expressed as arbitrary units of fluorescence per mg of hydroxyprohne 
and in some cases as units per mg dry weight tissue.
3.3 In vitro glycation o f collagen
Tissue (both corneal and scleral) and coUagens of knvwn weights (types I 
and IV from Sigma Chemical Company) were incubated in 0.5M glucose,
0.05M phosphate buffered saline, pH 7.4 and 3mM sodium azide at a 
temperature of 37° C for specified time periods. (Studies were also
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performed with 0.5M fructose and 0.5M ribose). The pH of the incubations 
was checked occasionally using a Schott Gerate pH meter (Model no. CG 
727) to ensure no change. The samples at glycation point ‘zero’ were 
incubated in buffer/azide for the entire period of the experiment. Following 
each specified time point, the samples were dialysed to remove any 
unreacted sugar incubated in fresh buffer for the remainder of the study in 
order to ensure that the changes observed in X-ray diffraction were not 
simply effects of alterations in tissue hydration brought about by prolonged 
incubation in the buffer at 37°C.
3.3.1 D ialysis o f g lycated  collagen
Dialysis was performed to allow removal of free sugars following in vitro 
glycation. These may have otherwise interfered in the biochemical assay for 
glycation. Dialysis tubing with a molecular weight cut-off of 12-14 kDa Was 
prepared by soaking in 1% acetic acid solution for 1 hr after which it was 
rinsed for approximately 30 mins in distilled water. The tubing was further 
soaked for 30 mins in a solution of 1% sodium carbonate with lOmM 
EDTA. The tubing was heated in this solution to 75°C. After heating in 
distilled water, the tubing was stored at 4°C in distilled water before use. 
Dialysis was performed at 4°C in approximately 2L of distilled water with 
several changes overnight.
3.4 Inhibition o f glycation and AGE  
form ation
Three compounds were chosen to investigate their effects on the in vitro 
glycation of corneal collagen. Corneal tissue (from 3 donors of similar age) 
was carefully sectioned and incubated at 37°C in 0.05M phosphate buffer 
(pH 7.4) with 0.5M fructose, 3mM sodium azide and an inhibiting 
compound, either 25mM acelylsalicylic acid (aspirin; ASP), 25mM
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diethylenetriaminepentaacetic acid (DETAPAC) or 25mM aminoguanidine 
(AG) for a period of 24 days in total. Control samples were incubated in 
thè absence of fructose. At each, time point (3, 6, 15 and 24 days) the tissue 
sections were dialysed overnight against distilled water to remove traces of 
sugar and inhibitor and the sections were reincubated in fresh phosphate 
buffer with sodium azide for the remaining period (to 24 days). Each tissue 
was examined using the high angle camera at the synchrotron radiation 
source at Daresbury.
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Chapter 4
Corneal Incubation M edium  
R esu lts and D iscussion
Leaching of proteoglycans and soluble proteins occurs when denuded 
corneas are placed in a bathing medium [Hughes, 1983]. The corneas used 
for the studies in this thesis were supplied as corneoscleral discs which had 
been stored in an incubation medium for up to 30 days at 34° C before 
investigation was possible; hence it was necessary to ensure that significant 
loss of protein or proteoglycan was not occurring from the tissue to the 
culture medium during this period. Although the CTS Eye Bank do not use 
corneas that have been stored in medium for such periods of time, it was of 
interest to investigate the efficiency of the medium during this period.
4.1 SD S-polyacrylam ide gel electrophoresis
This technique was employed to investigate protein loss from the culture 
medium. Essentially two types of experiment were performed :
1. an age-related study to investigate whether there was any relationship 
between the age of the cornea and the amount of protein lost
2. a time-related study to investigate the correlation betwqen the period of 
storage and the amount of protein lost.
Polyacrylamide gels were stained for protein and proteoglycan. However,
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using Alcian blue, proteoglycan staining was extremely faint hence a more 
sensitive assay was used, the results of which are presented in section 4.2. 
The results of the protein staining are given in Figures 4.1 and 4.2. Protein 
bands were seen at 45-66k, 66k and just above 66k (Fig 4.1, using a low 
molecular weight marker). From Fig 4.2, where a high m olecule weight 
marker was used, the larger protein band was approximately 76k in size.
4.2 Total glycosam inoglycan assay
A dye binding assay was used to measure the concentration of GAG within 
the culture medium. The method relies on the specificity of Alcian blue for 
GAG at a critical electrolyte concentration which minimises the staining of 
other negatively-charged glycoproteins. The assay was performed as a 
function of age and as a function of time, the results are presented in 
Table 4.1 and Table 4.2.
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F ig u re  4 .1  Age-related s tudy  ; 7.5% polyacrylamide gel stained with
Coomassie blue for protein  from corneal culture medium. M edium taken
from donor corneas of 6 weeks-88 years of age
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Age of donor (yr) and length of storage in medium (wk)
Marker
205K
116K
97K
66K
45K
29K
F ig u r e  4 .2  Time-related study  : 7.5% polyacrylamide gel stained with
Coomassie blue for protein from corneal culture m edium  of 4 corneas (ages
15, 21, 32 and 47 years) after storage periods of 1 and 3 weeks
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4.3 E lectron  m icroscop y
Cultured corneas, both young and old, were examined by electron 
microscopy. In particular, the staining of proteoglycans within these 
samples was compared with that of an uncultured cornea. The results are 
presented in Figures 4.3, 4.4, 4.5 and 4.6.
4.4 D iscu ss ion  o f  in cu b ation  m ed iu m  
stu d ies
Polyacrylamide gel electrophoresis suggests that proteins are lost from 
corneas of all ages to the corneal storage medium (Fig 4.1), as indicated by 
Coomassie blue staining. The 66k protein band is the most heavily stained 
and may well be albumin, however the incubation medium itself was 
investigated using SDS-PAGE and found to produce a heavily stained band 
at 66k. It is very likely that the foetal calf serum component of the culture 
medium is responsible for this band. A diffuse staining between 45-66k 
could represent a 54k protein described in bovine cornea. In all cases the 
loss of protein at bands 54k and 76k was unrelated to the age of the cornea 
that had been stored in that medium.
Since the corneas used in the X-ray diffraction and glycation studies had 
already been stored in the medium, in some cases for several weeks, it was 
necessary to investigate whether the period of storage was affecting the 
concentration of proteins (and proteoglycans for that matter) and in 
particular it was of interest to pin-point at what period of storage losses 
became important. From Figure 4.2, a heavily-stained protein band again 
appeared at 66k and was assumed to be the foetal calf serum component of 
the culture medium. A protein band also appeared between 66k and 97k 
although this was not as apparent in the medium taken from a 47 year old 
cornea. In this study medium was taken from 4 corneas (age 15-47 years) at 
two time points - 1 and 3 weeks. With the exception of the medium
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Age of stored cornea from Relative GAG
which medium was analysed concentration 
(years) (/^g ml"^)
4 6.43 + /-  0.28
26 0.98 A /- 0.11
35 2.50 + /-  0.21
43 14.10 A /- 0.15
50 10.00 A /- 0.19
62 3.65 A /- 0.21
75 12.18 A /- 0.25
89 2.88 A /- 0.23
Table 4.1 The level of GAG in the corneal storage medium of corneas aged 
from 4 to 89 years at a storage period of 3 weeks
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Corneal storage 
medium
Time at which 
aliquot of medium  
taken (wks)
Relative GAG 
concentration 
(//g ml“ )^
From 15 yr old cornea 1 0.98 + /-  0.15
3 10.0 + / -  0.20
From 53 yr old cornea 1 0.52 + /-  0.15
3 0.21 + / -  0.17
5 0.31 + /-  0.15
From 95 yr old cornea 1 0.61 + /-  0.16
3 14.42 + / -  0.20
5 14.10 + /-  0.18
T ab le 4 .2  The level of GAG in the corneal storage medium of 3 corneas at 
1, 3 and 5 weeks
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F ig u re  4.3 Electron micrograph showing cross-seciion through a Ciipro- 
linic bine stained 87 year old uncultured human cornea, couiiterstained for 
collagen with uranyl acetate. The proteoglycans are indicated by arrows. 
Magnification 86.000 i^Flectroii micrograph courtesy of I.M.Rawei
F ig u r e  4 .4  Electron micrograph showing cross-section through a Cuprohnic
blue stained 27 year old cultured hum an cornea. The proteoglycans are
indicated by arrows. Magnification 86.000
F ig u r e  4 .5  Electron micrograph showing cross-section through a Cuprohnic
blue stained 43 year old cultured hum an cornea. The proteoglycans are
indicated by arrows. Magnification 86,000
75
%F ig u r e  4 .6  Electron niicrograpli showing cross-section through a Cuproliiuc
blue stained 93 year old hum an  cultured cornea. The proteoglycans are
indicated by arrows. Magnification 86,000
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housing the 47 year old sample, the intensity of the protein bands remained 
unchanged from 1 to 3 weeks. Although there were losses of proteins from 
the tissue, most were unrelated to the age of the tissue. However, the 
amount of the 66-97k protein lost appears to decrease with age. All tissues 
that were eventually used for X-ray diffraction studies were selected such 
that they had been stored in the culture medium for equal periods. 
Polyacrylamide gel electrophoresis can also be used to look at the leaching 
of tissue proteoglycans. It simply involves using an Alcian blue stain for 
acidic or sulphated groups on G AGs [Wall and Gyi, 1988]. However, the 
lack of Alcian blue staining with PAGE implied no significant losses of 
proteoglycan to the storage medium, hence a more sensitive technique was 
employed - a microdetermination dye binding assay for GAGs. Table 4.1 
shows that proteoglycan loss is occurring from corneas across the entire age 
range, but there appears to be no relationship between its concentration at 
a specified time point and the age of the cornea stored in the medium.
Table 4.2 shows that proteoglycan loss to the storage medium is occurring 
from both the young and older corneas. In the cases of the 15 and 95 year 
old samples, the concentration of proteoglycan in the storage medium  
increases from 0.98-10.0 /ig nil~^ and 0.61-14.10 f ig  m l“  ^ respectively from 
1 to 3 weeks storage.
Figures 4.4, 4.5 and 4.6 demonstrate through Cuprohnic blue staining of a 
27 year old, 43 year old and 93 year old human cornea, that proteoglycans 
are still present within the corneal stroma and when compared with the 
electron micrograph of an uncultured human cornea given in Figure 4.3, the 
loss to the medium appears to be small. There also appears to be no 
significant difference in the proteoglycan content when comparing the three 
cultured corneas.
By binding to specific bands on the coUagen fibrils, proteoglycans affect the 
regularity and the parahel spacing of coUagen fibrils, and thus contribute to 
the transparency of the cornea. The loss of proteoglycans during organ 
culture was small and it is hkely that the intact corneal epithehal and 
endothehal ceU layers minimised this loss since Slack et al (1992) have
7'
shown that removal of these layers results in a three to fivefold greater loss. 
It has also been shown that, on removal of the corneal epithelium, 
glycoprotein loss is also increased. It is probable that the scleral rim and 
the intact epithelium and endothelium prevent leaching of proteoglycans 
and other constituents of the stroma. Hodson et al (1991) have shown that 
components of M,. 10 kDa cannot penetrate the epithelial cell layer or 
Descem et’s membrane. The results of Slack et al show that, with both the 
endothelial and epithelial ceU layers intact, only a 1% loss of proteoglycan 
occurs during corneal preservation (less than 2% after 14 days storage). 
These studies thus support the results of the corneal medium investigation  
in this thesis. It was therefore possible to use cultured corneas for the 
experiments described in the following chapters.
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Chapter 5
X -R ay D iffraction and G lycation o f  
T issue - R esu lts and D iscussion
This chapter will describe the results obtained from X-ray diffraction of the 
corneal and scleral tissues received from the CTS Eye Bank. In an attem pt 
to account for the results obtained, the levels of glycation of chosen corneas 
and scleras were also investigated along with levels of fluorescence. The two 
parameters of interest using X-ray diffraction were the spacing between 
adjacent coUagen molecules within the fibrils, and the centre-to-centre 
spacing between the fibrils themselves. However, when either of these 
spacings changes, the molecular or fibriUar network expands or contracts in 
t w o  dimensions. Hence the parameters of interest are 1) the (molecular 
spacing)^ which is referred to as the intermolecular unit ceU and 2) the 
(interfibrillar spacing)^, which is referred to as the fibril unit ceU. AU 
studies were carried out as a function of tissue age.
5.1 X-ray diffraction
Three studies were carried out, one in which corneal hydration was not set 
prior to analysis (Figures 5.1 and 5.2), a second in which it was set with 
polyethylene glycol to a value just below physiological (Figures 5.3 and 
5.4), and a third study where corneal and scleral hydrations were set as
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close to physiological as possible (Figures 5.5, 5.6 and 5.7). Although 
there is no reason to presume that the increase in the intermolecular unit 
cell of collagen is linear, the line of ‘best fit’ is plotted to indicate the trend 
in the data points.
5.2 Glycation
The levels of in vivo glycation of both corneal and scleral coUagen 
(Figures 5.8 and 5.9), were investigated by using the TEA assay. 
Fluorescence (370nm/440nm) was also read for both tissues (Figures 5.10 
and 5.11).
5.3 D iscussion
Figures 5.1 and 5.2 iUustrate respectively the changes in the coUagen 
molecular unit ceU and fibril unit ceU within human corneas as a function of 
age. The intermolecular unit ceU appears to increase with tissue age, 
however the increase is small with a correlation coefficient, r, of 0.43. Since 
the corneal hydrations were not set, corneal hydrations were found to vary 
between 1.8 and 5.0. However, this represents a true age effect because the 
size of the intermolecular unit ceU does not vary much above H=2.5 [Meek 
et al., 1991]. If this growth is linear it corresponds to a 7% increase from 
3.28 + /-  0.07nm^ (birth) to 3.52 + /-  0.12nm^ (age 90). In Figure 5.2 the 
interfibriUar unit ceU shows no apparent correlation with tissue age. In this 
case, the tissue hydration is probably responsible for the scatter of the data, 
since the interfibriUar spacing is very hydration dependent (Sayers et al., 
1982; Meek et al., 1991). In order to assess to what extent the observations 
in Figures 5.1 and 5.2 were due to variations in hydration, the experiments 
were repeated, this time setting the tissue hydration beforehand. As a 
starting point, 2.5% PEG was used, since this had been found to produce a 
physiological level of hydration in bovine corneas [Meek et al., 1991].
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Figure 5.1 Change in (intermolecular spacing)^ of human corneal collagen
with age (hydration not set, hence range of hydrations 2.2-4.5)
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Figure 5 .3  Change in (intermolecular spacing)^ of human corneal collagen
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F ig u re  5.11 Change in fluorescence of scleral collagen with age. A linear 
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However, in human corneas, this concentration of PEG produced 
hydrations of 2.5 (i.e. below 3.2, the value taken to represent approximately 
physiological hydration). The results are presented in Figures 5.3 and 5,4. 
In Figure 5.3 the intermolecular unit cell increases with age; the straight 
hne through the data corresponds to an increase of only 3% from 2.53 + /-  
O.lOnm^ (birth) to 2.62 + /-  0.19nm^ (age 90). However, in this case there 
were fewer data points at the lower end of the age range, and from Figure 
5.1 the younger corneas tend to show lower intermolecular spacings. In 
Figure 5.4 the fibril unit cell appears to decrease shghtly with tissue age, 
and in this case a streiight Hne through the data represents a reduction of 
8%, from 2791 4-/ 35nm^ (birth) to 2555 + /-  20nm^ (age 90).
In a later study (Figures 5.5 and 5.6) the corneal hydrations were set to 
approximately 3.4 using 1.5% PEG. The straight Hne through the data of 
Figure 5.5 corresponds to an increase of 14% in the intermolecular unit cell, 
this is an increase from 3.04 + /-  0.15nm^ (birth) to 3.46 + /-  0.25nm^ (age 
90). Figure 5.6 shows that there is a reduction in the interfibriUar unit ceU 
as did Figure 5.4. However, at a hydration closer to the physiological level, 
the reduction in the fibril unit ceU is greater. A straight Hne through the 
data points impHes a reduction of 15% from 3550 + /-  20nm^ (birth) to 
3018 + /-  8nm^ (age 90). The calculation of correlation between the 
(interfibriUar spacing)^ and the age of the tissue gives a Hnear correlation 
coefficient of r=-0.84.
Figure 5.7 shows the increase in the intermolecular unit ceU of human 
scleral coUagen from birth (2.65 + /-  O.llnm^) to 90 years of age (3.19 + /-  
0.18nin^). This impHes that the intermolecular unit ceU increases by 20%, a 
greater increase than that found in human cornea across the same age 
range.
In the corneal stroma, the TEA assay shows that there is an initial increase 
in the glycation of coUagen with age (Figure 5.8). After the age of about 50 
years, the curve appears to level off suggesting the attainment of an 
equiUbrium or steady-state with respect to extraceUular glucose 
concentration and possibly an equiUbrium between the amount of AP and
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AGE. Over the age range, the concentration of HMF generated from the 
Amadori product increases from 6.9 to 10.4 nmol per mg dry weight of 
tissue; In co n tra t, scleral collagen shows a progressive increase in glycation 
across the entire age range, from 0.68 to 4.68 nmol per mg dry weight of 
tissue (Figure 5.9). The one point on this graph that shows an HMF 
concentration of approximately 9 nmol/mg dry weight tissue, greater than 
aU the other points, may well represent an individual with impaired glucose 
tolerance since ageing is known to be associated with impaired control of 
glucose [Harris et al., 1987]. The difference in the trends in glycation of 
corneal and scleral coUagen may reflect age-related differences in tissue 
coUagen composition or coUagen turnover. The corneal stroma is known to 
have a glucose concentration of 8.8^mol/g dry weight tissue [Reim et 
al.,1967). With ageing, this may weU increase as the body becomes less 
tolerant .to glucose and may contribute to the higher levels of fluorescence 
found in older individuals.
Figure 5.10 demonstrates the change in the fluorescence of corneal coUagen 
with corneal age. Although a Une of best fit has been drawn through the 
data to indicate the trend in the data points, it is unclear whether the 
increase is Unear and whether it continues beyond the age of about 30 years 
since the level of scatter in the data increases (the result of individual 
variation). These data suggest that the level of fluorescent AGE increases 
in the first three decades of Ufe. The fluorescence of scleral coUagen on the 
other hand. Figure 5.11, does show a clear Unear increase across the entire 
age range from almost zero at birth to approximately 2.6 arbitrary units of 
fluorescence at 80 years of age. The Unear correlation coefficient, r, in this 
case was 0.89. These data imply that the level of fluorescent AGE increases 
with scleral age.
Since AGEs have been proposed as cross-Unking structures [SeU and 
Monnier, 1990] and their concentration has been observed to increa.se in 
human corneal and scleral coUagen, it is possible that, by occurring at 
specific points between coUagen molecules, these structures are responsible 
for the increase in the dimensions of the molecular unit ceU of coUagen in
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both cornea and sclera (14% and 20% respectively). Any age-related 
changes in stromal glucose concentration would increase the availibility of 
sugar for glycation. As a result, one would expect the size of the molecular 
unit cell of collagen to be larger at the older end of the age range which is 
suggested by Figures 5.5 and 5.7. On re-inspection of these graphs, 
although there is an overall increase in (intermoleculax spacing)^, the 
greatest absolute changes could be occurring between birth and 40 years of 
age i.e. developmental changes of ageing.
Tanaka et al (1988) concluded from their in vitro studies that, the major 
structural alteration caused by the glycation of rat tail tendon was in the 
lateral direction, perpendicular to the fibril axis and represented an increase 
in the spacing between the collagen molecules in this tissue. They also 
concluded that only a subset of cross-hnks causes any significant structural 
change, i.e. those that he perpendicular to the molecular axes. It is possible 
that the increase in spacing between the molecules of collagen in cornea and 
sclera found in this chapter is the result of glycation-derived cross-Hnks.
The observation of the reduction in the size of the fibril unit cell with 
corneal age is likely to be hnked to alterations in the proteoglycan content 
or composition of the tissue. Studies to confirm age-related changes in 
corneal proteoglycan levels were not carried out in this particular project 
and they are also, as yet, undocumented elsewhere. An electron 
microscopical study was however performed by Kan ai and Kaufman (1973) 
in which they too concluded that the volume of the fibril unit cell reduces 
with comeal age. Unfortunately their study included only three corneal 
specimens and did not produce absolute values for the volume change that 
occurred. A great advantage of X-ray diffraction is that tissues may be 
examined in as close to their natural state as possible. Since processing , 
steps such as dehydration and embedding, which are required for electron 
microscopy, are not needed here, there is a smaller chance of artefactual 
results.
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Chapter 6
X -R ay D iffraction o f In V itro  
G lycated  T issue Collagen - R esults  
and D iscussion
To account for the increased expansion of the molecular unit cell with 
increasing corneal and scleral age, in vitro studies were performed to see 
whether the results could be replicated in a ‘model system’. On this 
occasion experiments were performed as a function of time. Since sugar 
concentrations that were higher than those normally existing within the 
body were used, the moleculcir expansions occurred at accelerated rates. 
Different sugars were employed so that molecular changes resulting from 
ribation and fructation could also be studied.
6.1 X-ray diffraction and fluorescence 
studies
In vitro glycation, as described in section 3.3, was carried out with type I 
collagen (containing small quantities of types III and V) from both human 
cornea and sclera. Figure 6.1 and Figure 6.2 illustrate respectively the 
changes in (intermolecular spacing)^ and AGE levels (as measured by 
fluorescence emission) with period of incubation of corneal collagen in the
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sugar/birffer mixture. Figures 6.3 to 6.8 show the equivsJent changes in 
sclera at 3 different ages.
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F igu re  6,1 Change in (intermolecular spacing)^ of in vitro glycated corneal 
collagen with time (middle-aged corneal specimen used)
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F ig u re  6.2 Change in fluorescence of in vitro glycated corneal collagen with 
time (middle-aged corneal specimen used)
The effect of in vitro incubation of scleral type I collagen was investigated 
using three scleras between the ages of 43-46 years. Three different sugars, 
namely ribose, fructose and glucose were used and the results are presented 
in Figures 6.9 and 6.10.
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Figure 6 .4 Change in fluorescence of in vitro glycated scleral collagen with
time (middle-aged scleral specimen used)
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Figure 6.6 Change in fluorescence of in vitro glycated 6wk old scleral col­
lagen with time
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6.2 D iscussion
Figuré 6.1 illustrates that, following an initial lag phase of 2 weeks, the 
intermolecular unit cell of corneal collagen (taken from a 43 year old 
specimen) increases from 3.21 + /-  0.25nm^ at time zero (this was the 
measurement of the control sample which had been incubated at 37° C in 
the absence of sugar throughout the experiment) to 4.90 + /-  0.51nm^ after 
a period of 5 weeks incubation with 0.5M glucose. Similarly the corneal 
fluorescence, reflecting the level of AGE (Figure 6.2), increases from 8.89 
(at time zero) to 58 arbitrary units/m g dry weight collagen after 5 weeks 
exposure of the collagen to glucose. The correspundiug sclera of this 43 
year old sample was also used in the in vitro investigation and produced a 
change (Figure 6.3) in the volume occupied by the scleral collagen 
molecules of 14% from 3.13 + /-  0.20nm^ (time zero) to 3.66 -f-/- 0.33nm^ (5 
weeks). Figure 6.4 shows that the level of collagen fluorescence (at 
370nm/440nm)) in this sclera also increased with period of incubation. 
Figure 6.5 shows the change in the volume of the intermolecular unit cell of 
scleral collagen from a 6 week old human sclera. Overall, there is an 
increase in the dimensions of the molecular unit cell from 2.84 + /-  0.23nm^ 
(time zero) to 3.66 + /-  0.20nm^ (at 5 weeks incubation) i.e. an increase of 
22%. The level of fluorescence, given in Figure 6.6, also increases from zero 
to 5 weeks producing a very similar curve to that obtained with 
middle-aged scleral collagen.
Figure 6.7 shows the intermolecular unit cell of collagen from an 80 year old 
sclera. Again a rapid increase in volume is observed from zero to 1 week 
however, between 1 and 3 weeks of incubation, the volume of the 
intermolecular unit cell remains fairly constant. From zero to 5 weeks of 
incubation the overall increase is from 3.08 -f/- 0.26nm^ to 4.70 -f/- 
0.72nm^ respectively, an expansion of the molecular unit cell of 34%.
Figure 6.8 illustrates the same trend as did Figures 6.4 and 6.6, that the 
level of AGE increases from zero to 5 weeks of incubation.
From the observed changes in the (intermolecular spacing)^ of human
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collagen taken from sclera of three different ages, there is no apparent 
relationship between the age of the collagen and the size of the expansion of 
the molecular unit cell. This suggests that collagen in younger individuals 
is no more susceptible to glycation than collagen in older individuals. 
Comparing the change in the molecular unit cell of a middle-aged cornea 
and its corresponding sclera, i.e. Figures 6.1 and 6.3, the expansions of 35% 
and 14% respectively imply that corneal coUagen undergoes greater 
molecular change than does scleral collagen over a specified time period. 
Although more sets of data are required to confirm whether this is 
happening, it is interesting to note that at 43 years of age, from the lines of 
regression in Figures 5.5 and 5.7, the calculated values for (intermolecular 
spacing)^ in cornea and sclera are 3.25 and 2.91nm^ respectively. It is 
difficult to compare the level of AGE found in the 43 year old cornea and 
sclera (Figs 6.2 and 6.4) since the technique used does not provide us with 
an absolute concentration of AGE, hence it can only be commented that 
the level of fluorescent AGE increases in both tissues continuously from 
zero to 5 weeks incubation. In both cases there is a rapid initial reaction 
followed by a slower reaction phase. This could be due to a change in 
coUageu conformation eventually exposing the slower reacting sites on the 
collagen molecules.
In vitro investigations of the glucation, fructation and ribation of human 
scleral collagen produced the preliminary results illustrated in Figures 6.9 
and 6.10. All three sugars produce an increase in the dimensions of the 
molecular unit cell of scleral collagen between zero and 20 days incubation. 
The initial rates of increase (between zero and 5 days) in the (intermolecular 
spacing)^ are as follows : 0.09nm^/day (glucose), 0.04nm^/day (fructose), 
O.llnm^/day (ribose). These rates suggest that ribose reacts initially at a 
faster rate than the other sugars. The rates of increase between 5 and 10 
days also suggest that ribose is reacting faster than both fructose and 
glucose and all the rates have slowed down, 0.04nm^/day (glucose),
Onm^/day (fructose) and Q.lOnm^/day (ribose). The rates of change 
between 15 and 20 days were 0.12nm^/day (glucose), 0.07nm^/day
103
(fructose) and 0.50nm*/day (ribose). The corresponding fluorescence of the 
scleral collagen samples increases with the period of incubation with the 
three sugars used. Up to 10 days, the graph suggests that ribose and 
fructose are both reacting at considerably faster rates than glucose. 
Following the 10 day incubation period, glucose continues to produce the 
least fluorescence and fructose produces the greatest. It is diflGicult to attach 
any significance to the apparent drop in fluorescence with ribose at 10 days 
since the accuracy of the fluorescence measurements cannot be quantified, 
hence it is only the continuing trends that can be commented on.
The expected order of rate of reaction would be ribose>fructose>glucose.
The pentose ring structure of ribose cannot react with amine groups in the 
triple helical collagen molecule since the carbonyl group is unavailable on 
this sugar in this form. In solution however, a significant proportion of 
ribose exists in the straight chain form to allow ribation to occur at a faster 
rate than fructation and glucation. A greater proportion of fructose than 
glucose exists in the straight chain form in solution since the ring structure 
of glucose is very stable. After 10 days fructose appears to be producing 
higher levels of fluorescence than both ribose and glucose. There is a 
chance that secondary protein glycation is occurring i.e. fructation of the 
AP to produce AGEs [Ahmed, 1992]. The changes in intermolecular 
spacing and fluorescence appear also to run in parallel with the exception of 
fructose after prolonged incubation. At this point it is possible that 
fructation is producing fluorophores that do not affect intermolecular 
spacing. Obviously, more data are required to confirm the rate of reaction 
observed in this study. However, although these data are preliminary, they 
are the first to have been obtained with scleral collagen and the first to 
have been expressed as an effect on the intermolecular unit cell. With 
reference to the study of the effects of different sugars, comments have been 
made on the observed trends since it is difficult to comment on individual 
data points because three different scleras were used and, although they 
were of similar ages, individual variations undoubtedly existed.
Most in vitro glycation studies by other workers have not incubated
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proteins beyond 4-5 weeks. This study extended the incubation of human 
scleral collagen with fructose to a period of 6 weeks. Three donor scleras 
were used (aged 6 weeks, 43 years and 80 years) and, interestingly beyond 5 
weeks of incubation, the (intermolecular spacing)^ of the collagen dropped 
along with the level of fluorescence (Figure 6.11). Although physiologically 
this reduction in (intermolecular spacing)^ may not be of considerable 
importance, it was interestingly observed several times.
It is unclear as to why this should occur but it suggests that the in vitro 
conditions (using higher concentrations of sugar than would otherwise be 
found in the euglycaemic individual) at 6 weeks result in a breakdown of 
the AGE cross-linking produced over the first 5 weeks. The result is 
possibly a more stable structural arrangement.
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cChapter 7
Investigation  o f D ifferent C ollagen  
Sources - R esu lts and D iscussion
The previous chapters have been concerned with the alterations in type I 
collagen from the human cornea and sclera. Type I collagen from various 
different tissues is supplied by the Sigma Chemical Company. Type I 
collagen from bovine tendon, calf skin, human placenta eind rat tail tendon 
was investigated along with type IV collagen from human placenta. These 
coUagens were glycated in vitro to compare their susceptibility to sugar 
attack.
7.1 G lycation and fluorescence
The levels of glycation as measured by the TEA assay are presented as 
nmols of Amadori product per mg of collagen in Table 7.1 and the 
corresponding levels of AGEs are illustrated in Table 7.2. The results are 
also represented graphically by Figures 7.1 - 7.4, curves were fitted 
according to the method of least squares. Table 7.3 is a summary of the 
increase in the level of glycation between 0 and 30 days of incubation of the 
different coUagens.
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Time of incubation I I I IV
calf skin bovine tendon rat tail human placenta
0 2.68 1.24 1.92 3.02
5 3.71 2.82 -
10 5.02 6.19 - -
20 9.14 8.11
30 14.78 12.85 25.70 22.00
Table 7.1 Glycation of collagen types I and IV as measured by the TEA 
assay ; glycation is expressed as HMF (nmol)/mg collagen, time of incubation 
is expressed in days
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Time of incubation I
calf skin
I
bovine tendon
I
rat tail
IV
human placenta
0 3.38 1.33 0.36 0.44
5 4.80 1.09 - . -
10 5.80 1.23 -
20 3.30 2.22 -  ■ -
30 3.73 4.72 2.16 3.22
Table 7.2 The levels of fluorescence resulting from in vitro glycation of col­
lagen types I and IV; fluorescence is expressed as arbitary units/mg collagen, 
time of incubation is expressed in days
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Rat tail tendon is the most likely of all the tissues investigated to contain 
predominantly type I collagen, hence the Sigma preparation of this type I 
collagen will be pure type I compared with the other type I sources which 
are more likely to be collagen mixtures.
From Table 7.1, a comparison of type I collagen from calf skin with that 
from bovine tendon shows the former to be more highly glycated (in vivo) 
at time zero than the latter and it also achieves a greater level of glycation 
at every time point (with the exception of 10 days incubation). Type IV 
collagen shows a greater level of in vivo glycation (at time zero) and, after 
30 days, becomes more glycated than type I from both calf skin and bovine 
tendon. Type I collagen from rat tail, assumed to be the purest form of 
type I collagen as supplied by Sigma, shows an even greater level of 
glycation than type XV after 30 days exposure to sugar. Type IV collagen is 
a basement membrane collagen and in human placenta would be in close 
proximity of a rich blood supply hence a good sugar source. This particular 
collagen type would, in this case, be expected to be more susceptible to 
glycation than type I collagen. The differences in glycation of these two 
coUagens may reflect differences in purity.
The fluorescence values (Table 7.2) also reflect a greater production of 
fluorescence at each point of incubation of type I coUagen from calf skin 
with sugar compared with that from bovine tendon. However, after 30 
days, the level of fluorescence is highest for bovine tendon type I coUagen. 
After 30 days incubation with 0.5M glucose (Table 7.3) type I (from rat 
tail) and type IV (from human placenta) produce the largest absolute 
increases in HMF concentration whUst type I from calf skin zind bovine 
tendon, produces a smaUer change.
The in vitro studies (described in Chapter 6), using type I coUagen from 
human cornea and sclera, showed an increase in the level of fluorescent 
AGE with period of incubation. The Sigma type I coUagen, obtained from 
bovine achiUes tendon, calf skin and rat tail demonstrate a simUar increase. 
AU the coUagens demonstrated an increase in the level of AP with period of 
incubation suggesting that the level of glycation increased with time in each
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oCollagen type Glycation after 30 days
I (rat tail) 23.78
IV (human placenta) ■ 18.98
I (calf skin) 12.10
I (bovine tendon) 11.61
Table 7.3 The increase in the level of glycation after 30 days of exposure 
to sugar; glycation expressed as HMF (nmol)/mg collagen
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o
case (Table 7.1). Similarly they all showed an increase in the level of 
fluorescence (with the exception of type I coUagen from calf skin which 
showed a peak fluorescence at 10 days), possibly reflecting increasing levels 
of AGE, with time.
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Chapter 8
Inhibition of Pre- and P ost-A m adori 
R eactions - R esu lts and D iscussion
The initial reaction between coUagen and a sugar molecule produces a labUe 
Schiff base adduct. An Amadori rearrangement leads to the formation of a 
relatively stable Amadori product. Through a series of rearrangements, 
dehydration and hydrolysis reactions, the Amadori adduct is able to yield 
highly reactive dicarbonyl sugars such as 1- and 3-deoxyglucosone. These 
dicarbonyl sugars are precursors of fluorescent AGEs, The formation of 
AGEs (both fluorescent and non-fluorescent) can be stimulated by oxygen 
and catalysts of oxidation reactions, such as iron and copper ions. It is now 
thought that the only nonenzymaticaUy formed, carbohydrate-derived 
products known to accumulate in tissue proteins with age, are products of 
both glycation and oxidation reactions. The interplay between glycation 
and oxidation - ‘glycoxidation’ of a protein - may be of more importance 
than either of them alone.
The reactions occurring before the formation of the Amadori product are 
referred to as pre-Amadori reactions and are essentiaUy non-oxidative, 
those occurring after the rearrangement are known M post-Amadori 
reactions, these are Ukely to foUow both oxidative and non-oxidative 
pathways. The inhibition of these reactions has been investigated.
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o8.1 R esults
In this study, corneal tissue firom three corneas of similar ages (46-53 years), 
WcLS incubated with 0.5M fructose in phosphate buffer at 37°C and a 
specified inhibitor (the concentration of the inhibitor in each case was 
25mM). The experiment was designed to look for changes in the 
intermolecular unit cell with the time of incubation in fructose with and 
without inhibition. The results are presented in Table 8.1.
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Reading down each column, the table shows that all three compounds, 
aminoguanidine (AG), acetysalicyhc acid (ASP) and
diethylenetriaminepentaacetic acid (DETAPAC), successfully inhibited the 
expansion of the collagen molecular network associated with fructation. In 
the absence of an inhibitor, the unit cell increased by 30% after 24 days, 
compared with 0% (AG), 11% (ASP) and -11% (DETAPAC). At time zero, 
the unit cell in the control was larger than those in the other three corneas. 
This was probably because the closest control sample available at the time 
was 10 years older than the test samples.
8.2 D iscussion
The apparent 17% reduction in the molecular unit cell during the early 
stages of incubation with AG is significant (p<0.05). DETAPAC also 
produces a significant reduction (p<0.05) in the unit cell size of 10% over 
the same period whilst ASP produces no significant change. Fructose was 
unable to cause an expansion of the corneal coUagen molecular network in 
the presence of the three inhibiting compounds used. This suggests a 
hindrance in the production of new cross-links. Aspirin (acetylsaUcylic 
acid) (Figure 8.1) acts by blocking the free amino groups of corneal coUagen 
by acetylating them. This subsequently prevents the production of AP and 
AGEs i.e. an inhibition of both glycation and AGE formation. Aspirin has 
been shown to reduce the glycation of albumin and haemoglobin [RendeU et 
al., 1986] and also lens protein [Swamy and Abrziham, 1988]. 
Aminoguanidine, on the other hand, has been suggested to block free 
carbonyl groups [Brownleo et al., 1988]. Free carbonyl groups exist within 
the sugar used (i.e. fructose) and within reactive dicarbonyl compounds, 
such as 3-deoxy glucosone, produced from the AP. The result is an 
inhibition of post-Amadori reactions whereby, glycation may be affected if 
the aminoguanidine attacks the sugar, and cross-link formation is 
prevented. This is iUustrated in Figure 8.2.
DETAPAC (Figure 8.3) is a known metal ion chelator [Hunt et al., 1988].
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Inhibitor AG ASP DETAPAC no inhibitor
Days of incubation
0 2.69 2.69 2.69 3.08
3 2.22 2.69 2.66
6 2.22 2.69 2.43 3.35
15 2.22 2.69 2.69 4.01
24 2.69 2.99 2.40 4.01
Table 8.1 The effect of various inhibitors on the intermolecular volume of 
corneal collagen; intermolecular volume expressed as (Intermolecular Bragg 
spacing)^ nm^
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Since one route to AGE formation is suggested to involve autoxidation 
reactions catalysed by metal ions, DETAPAC would inhibit these reactions 
by removing the catalysts. From the study in this chapter, DETAPAC 
effectively prevented the increase in molecular unit cell dimensions that 
otherwise occurs with sugar.
It must be emphasised that this particular study has been a preliminary 
one and is the first to express the effects of inhibition of glycation and AGE 
formation on intermolecular volume. Although the effect of the inhibitors 
alone has yet to be studied, the results presented at this stage strongly 
suggest that aU three compounds successfully prevented the increase in the 
molecular unit cell that occurs with fructose alone.
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Chapter 9
Final D iscussion
The work of this thesis, as outlined in the aims and objectives, has revealed 
several age-associated changes in corneal and scleral collagen. The 
structural alterations that have been observed within the collagen have 
been reproduced by in vitro glycation experiments as hoped. The 
concentration of AGEs has also been shown to increase in comeal and 
scleral collagen with age and could be linked to cumulative glycation-based 
changes and changes in glucose levels on ageing of an individual. Although 
these changes are small, they have now been consistently observed and are 
found to be greatly accelerated under diabetic conditions [Brennan, 1989]. 
These structural alterations have been discovered and quantified as part of 
this thesis using a high intensity synchrotron source. Since this technique, 
unlike many others, allows tissue to be kept in as natural state as possible, 
the observations are more accurate than, for example, electron microscopy 
used by other workers.
The X-ray diffraction studies have determined the (intermolecular spacing)^ 
to increase with age in corneal and scleral type I collagen respectively. In 
conjunction with this, the level of glycation also increases in both tissues.
In the cornea, the amount of collagen glycation appears to reach a plateau 
after approximately 40 years of age and, on reinspection of Figure 5.5, the 
size of the molecular unit cell may also do the same. The level of 
fluorescence, at 370nm/440nm, also appears to increase with tissue age
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although the increase in scleral collagen is more noticeable (r=0.89). From 
the studies performed, the production of AGE reflects production of ‘new’ 
cross-hnks. It is very likely, from the observations, that such structures are 
responsible for the progressive alteration in the collagen molecular unit cell 
of both tissues and that the observed expansion represents the average 
spacing of normal and cross-linked molecules.
The cross-Hnking structure heis been quantified through fluorescence using 
excitation/ emission wavelengths characteristic of a known fluorescent 
cross-Hnk identified in human skin collagen. Pentosidine is the only 
well-characterised cross-Hnk formed in the Maillard reaction of sugars with 
proteins under physiological conditions. The wavelengths chosen for the 
study were not optimum for pentosidine (since it is likely that 
non-pentosidine cross-links are involved) but appeared to be the most 
sensitive to gly cation-induced change. The pentose ring structure is coupled 
to both an arginine and lysine residue. The involvement of a pentose in the 
cross-Hnk would be unexpected since, for one reason, the total plasma 
concentration of pentoses in humans is 100 times less than that of glucose. 
This observation may, however, have evolutionary significance since rodents 
have very high ribose concentrations and a short Hfespan [Heaf et al., 1976]
- this could be Hnked to accelerated ribose-mediated cross-Hnking. Ribose 
may be the major precursor of pentosidine in vivo. It is true that, in a 
diseased kidney, this sugar would be cleared at a slower rate. Any 
accumulation of ribose, or any other sugar for that m atter, would 
potentially allow protein glycation foUowed by AGE production. Since 
pentoses in aqueous solutions contain a higher percentage of the non-cycHc 
carbonyl (the reactive group of the sugar molecule involved in glycation) 
than hexoses, they are more susceptible to autoxidation [Bunn and Higgins, 
1981] - this may also lead to AGE formation. The concentration of 
pentosidine in human lens and skin coUagen has been found to increase 
gradually with age. However, the concentration observed in older tissues 
has not been reported to reach significantly high concentrations. It has been 
predicted that, the concentration of pentosidine in human skin coUagen of
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approximately 90 years age, could reach a level at which it could increase 
the cross-hnking of triple helical coUagen by 10% [SeU and Monnier, 1990]. 
The results of this thesis suggest alterations in the molecular unit ceU size 
in the order of 14% (corneal coUagen) and 20% (scleral coUagen). Although 
concentrations of pentosidine may be low, it is highly likely that other 
sugar-derived cross-Unks are present at the same time in vivo.
Recently it has been reported that the extent of glycation of lens proteins 
does not increase with age [Patrick et al., 1990]. The discrepancies may He 
in differences in assay procedures and sample populations used by different 
laboratories. The TBA assay used in this thesis is known to be subject to 
interference by 6-carbon sugars [Schleicher and Wieland, 1981] with 
acid-labUe glycosidic bonds. The major source of these sugars are the 
corneal proteoglycans, however, prolonged extraction in 4M guanidine 
hydrochloride should overcome this problem by removing the proteoglycans 
[WaU, 1990]. Incomplete removal of proteoglycans or other contaminating 
substances results in an interference with the TBA assay of less than 10% 
since borohydride reduction experiments have shown that, more than 90% 
of the colour generated in the TBA assay is derived from non-enzymicaUy 
glycosylated coUagen [Ahmed et al., 1992]. Under our conditions therefore, 
the TBA assay results can be taken to indicate an age-related increase in 
AP (i.e. glycation). The autoclave version of the TBA method by Parker et 
al was used in this thesis. It has the advantage of requiring only 1 hour of 
boUing whereas earUer versions involved between 4 and 6 hours, hence they 
were time-consuming. The Parker method was modified further during this 
thesis to increase the assay sensitivity and the yield of HMF (an indirect 
measure of AP). During this thesis, the method was also adapted for use 
with a microplate autoreader, resulting in a simple and rapid microassay. 
The experiments concerned with the effect of different sugars on the 
molecular unit ceU of human scleral coUagen (Chapter 6) suggested that 
ribation and fructation induced greater alterations in unit ceU dimension 
than did glucation. In vitro studies using radiolabeUed sugars have shown 
that fructose indeed reacts faster than glucose and forms the SB
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approximately eight times faster than glucose with hjaemoglobin [Bunn and 
Higgins, 1981]. Fructose has also been shown to induce AGE formation up 
to ten times faster than glucose in vitro with albumin [Suarez et al., 1989]. 
There are regions in the body where fructose can accumulate and in these 
regions the sorbitol pathway exists. This pathway has been identified in 
corneal epithelium and is responsible for converting excess glucose to 
sorbitol and fructose as illustrated in Figure 9.1.
Since impaired glucose tolerance occurs with age [Harris et al., 1987], there 
is a chance that the sorbitol pathway may become more active. The 
production of fructose would increase, which in turn would increase the 
likelihood of fructation of a long-lived protein such as coUagen. Direct 
evidence of fructation has been reported by McPherson et al (1988) who 
suggested that 20% of the AP in lens protein is derived from fructose. 
Sorbitol would also induce ceUular damage since it would accumulate 
intraceUularly to produce severe osmotic alterations - this may play a role 
in corneal epitheUal diabetic abnormalities.
The major structural alteration in coUagen caused by glycation is suggested 
by Tanaka et al (1988) to be in a lateral direction, perpendicular to the 
fibril axis. These workers suggested an expansion of the lateral dimensions 
(Figure 9.2) of a unit ceU describing the three-dimensional crystaUine 
packing of rat tail tendon coUagen. The increase in spacing between the 
coUagen molecules (of approximately 12%) was confined to a single plane of 
the structure - essentiaUy the plane at right angles to the fibril axis. The 
plane was one of the three major planes of the proposed quasi-hexagonal 
structure of rat tail tendon coUagen.
The expansion of the molecular unit ceU of both corneal and scleral 
coUagen is not simply an effect of changes in tissue hydration resulting from 
the presence of free sugar, since the in vitro studies used tissue samples at 
time zero which were incubated in the sugar/buffer mixture throughout the 
entire period of the investigation. Alterations in the (intermolecular 
spacing)^ occurred in the tissue samples at subsequent time points.
Since the cross-Unk pentosidine contains a lysine and arginine residue, it is
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Figure 9.1 A diagrammatic representation of the sorbitol pathway found in 
corneal epithelium. Enzymes - A, aldose reductase; B, polyol dehydrogenase; 
C, ketohexokincLse; D, aldolase
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Figure. 9.2 Changes in the ab plane of the qnasihexagonal unit cell of rat 
tail tendon collagen after incubation with 0.2M ribose. Unit cells at 0 and 
17 days are illustrated, the ‘new’ positions of the collagen molecules in the 
native structure are indicated by the circles (reproduced from Tanaka et al., 
1988)
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likely that it is occurring between adjacent collagen molecules, possibly in 
the overlap zone of the fibril. This may account for the lateral expansion 
observed by Tanaka et al. Although this group of workers did not 
investigate AGEs, they have postulated that molecules could be pushed 
along a considerable length in directions away from a cross-Hnk site as 
opposed to the locaHsation of a cross-Hnk effect. They suggest too that a 
consequence of this expansion is the entry of water into the fibril. A greater 
volume of water within the fibril would suggest less water between the 
fibrils and the overall result would imply a reduction in the interfibriHar 
distance. This is one of the observations made in this thesis. Sugar-derived 
cross-Hnks are therefore more Hkely to occur where lysine, hydroxylysine 
and possibly arginine residues exist on adjacent molecules at the same axial 
position and are more or less directly opposite each other. Only those 
. sugar-derived cross-Hnks occurrring at right angles to the fibril axis would 
produce such structural alteration - this impHes that only a subset of AGEs 
is responsible for the changes in the molecular unit ceU of coUagen, namely, 
relatively rigid sugar-derived cross-Hnks pushing apart adjacent molecules 
in the closely packed overlap regions of fibrils. Naresh and Brodsky (1992) 
have recently suggested that there are differences in the lateral packing of 
coUagen molecules in young and old rat taU tendon. Using X ray 
diffraction, they found the intensities of the 14-18th order meridional 
reflections to be sensitive to the conformation of the terminal non-heUcal 
peptides (known as telopeptides). The increase in spacing between the 
coUagen molecules may very weU result in conformational changes of the 
relatively flexible telopeptides.
During the investigation of inhibition of glycation and AGE formation, the 
metal ion chelator DETAPAC was used. Transition metal ions are potent 
catalysts of autoxidative reactions which can result in AGE formation. The 
copper concentrations within human cornea and sclera are 10 and 8 /ig g"^ 
fresh tissue respectively [de Azevedo and de Jorge, 1965]. The 
concentrations of such ions may change with age, possibly increase with age 
since fcee metal ions are constantly being released during ceU death.
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phagocytosis and inflammation - this would encourage AGE formation. 
Oxygen radical scavengers also exist within the body to Hmit the 
biomoleculcir damage caused by autoxidative reactions. One such scavenger 
is vitamin C (ascorbate) however, its concentration has been found to 
decrease in corneas of 40 years upwards [Seidler-Dymitrowska, 1953]. 
Although natural defence mechanisms Hmit the accumulation of products of 
autoxidation, in long-Hved proteins, such as coUagen, products of oxygen 
radical reactions can accumulate with time. These products may contribute 
to the molecular alteration of coUagen. Although protein aggregation and 
the formation of fluorescent cross-Hnks can be induced by free radical 
attack on any protein, glycated proteins are far more susceptible [Jones and 
Lunec, 1987].
It was noted, during the in vitro investigations in this thesis, that the 
longer the tissue had been incubated in sugar/buffer mixture, the more 
brown it appeared in colour. At the same time the tissue became stiffer and 
more resistant to enzymic digestion. Older corneal and scleral tissues were 
more difficult to digest with enzymes suggesting extensive cross-Hnking in 
older coUagen.
Glycation may take place at biologicaUy important sites of the coUagen 
molecule, for example the coUagenase binding site or a glycoprotein 
interacting site. In the glomerular basement membrane of the kidney, the 
glycation of the main coUagenous domain NCI, located at the carboxyl end 
of type IV coUagen molecules, may interfere with the normal assembly of 
type IV coUagen molecules in diabetes and is possibly related to the 
abnormal basement membrane function in this condition. CeU culture 
studies by Danne et al (1993) using glomerular epitheUal and endotheHal 
ceUs have shown that these ceUs, when exposed to 30mM glucose for 60 . 
hours, synthesize type IV coUagen at a rate 2 3 times greater than at 
physiological glucose levels. They also found that the stimulatory effect on 
type IV coUagcn production was only slowly reversed after restoration of 
the glucose to a normal level. It has also been reported that stimulation of 
coUagen synthesis by a high glucose concentration is a seLf-Hmited
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phenomenon with long-term elevation of glucose even resulting in decreased 
collagen production [Silbiger et al., 1993]. This impUes that turnover slows 
down and, since coUagen is a long-Uved protein and AGE formation is a 
slow process, the HkeUhood of a cumulative buUd-up of AGEs is very 
possible. The production of the SB and the AP from glycation results in 
changes in the isoelectric point of the coUagen, this would in turn alter the 
molecular conformation. Other workers [Yue et al., 1983] have found that 
the tensUe strength of rat tail tendon coUagen alters with glycation. If the 
fibrils in a bundle become cross-Unked by sugar-derived cross-Unks formed 
between molecules of neighbouring fibrils, then this cross-Unking of adjacent 
fibrUs would result in a larger stress-bearing unit, hence the requirement of 
a larger force to break the tendon [Bai et al., 1992]. If this were to occur in 
human cornea and sclera, the rigidity of both tissues would be edtered. 
Glycation appears to be an important factor in mediating alterations in 
tissue morphology and in altering the biological and mechanical properties 
of a coUagenous tissue, such as cornea or sclera, in ageing.
Although this thesis has not studied the effects of glycation on corneal 
transparency, the tissue haa been observed to develop a brownish 
colouration. The buUd up of coloured AGEs would be expected to have 
some effect on the optical properties of the tissue.
The investigation of the different coUagens found that they had different 
susceptibiUties to sugar attack. Type I, from rat tail, and type IV, from 
human placenta, were more glycated than type I from either calf skin or 
bovine tendon over a 30 day incubation period. Differences in glycation 
levels would be expected since the tissues are located in areas where the 
blood supply varies as does the activity of metaboUc pathways.
It has been suggested that the hydroxylysine residues are targets for 
glycation. Table 9.1 shows several coUagen types and the 
lysine/hydroxy lysine/ arginine content of each type. One would expect type 
IV coUagen from human placenta to be more susceptible to glycation in 
vivo because of its location (in close proximity of a good blood supply) with 
respect to the other coUagens. Table 9.1 indicates that type IV coUagen
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potentially has a greater number of lysine and hydroxylysine residues for 
glycation than type I coUagen. However, the experimental results in 
Chapter 7 suggest that type I coUagen from rat taU tendon achieves a 
greater level of glycation than type IV coUagen from human placenta after 
30 days exposure to sugar. The differences may be a result of the existence 
of positive groups (on amino acid residues) adjacent to glycation sites 
which could promote catalysis of the Amadori rearrangement.
Residues/1000 residues I III IV V
Lysine 25 29 9 18
Hydroxylysine 11 6 49 34
Arginine 50 48 26 47
Total 86 83 84 97
Lysine + 36 35 58 50
Hydroxylysine
Table 9.1 The amount of lysine, hydroxylsine and arginine found in coUagen 
types I, III, IV and V (compUed from Burgeson (1082) and Jander et al 
(1984))
It is hkely that the conformation of the molecules (hence the accessibihty of
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sites for glycation) at the time of glycation, together with the proportions 
of triple helix and globular domains, play a role in determining why one 
collagen type should be more reactive than another.
The inhibition of AGE formation was investigated in order to prevent 
molecular alterations of both corneal and scleral coUagen. There is 
evidence, however, that the body itself is able to trace, capture and degrade 
proteins containing AGEs. Macrophages are thought to bind and degrade 
AGE-containing proteins via a specific ceU-surface binding protein. The 
binding protein is able to recognise carbonyl groups and has a molecular 
weight of 90 kDa [Radoff et al., 1988]. These macrophages have been 
investigated with respect to proteins such as albumin however, there is no 
evidence to suggest that they are involved in the same way in cross-Unkcd 
coUagen, indeed it is not known whether they are able to penetrate the 
corneal tissue.
Glycation has a profound effect on coUagen in vitro and, from the X-ray 
diffraction studies in this thesis, results in age-related alterations in the size 
of the corneal and scleral molecular unit ceU of long-Uved coUagen. It is 
hkely that the process is one factor in a series of modifications occurring 
during the process of ageing.
Another structural modification found to occur o n  the ageing of an 
individual was the decrease in the fibrU unit ceU of coUagen in the cornea. 
The 15% reduction from birth to approximately 90 years of age was 
suggested to be a result of age-related changes in proteoglycan 
concentration. Although a comprehensive study of proteoglycan alteration 
with age has not been reported, a decrease in the ratio of proteoglycan to 
coUagen was observed by Scott et al (1981). From the studies in this thesis, 
it is interesting to note that, even when corneas at each end of the age 
range are equiUbrated to the same hydration, there is a 14% increase in the 
molecular unit ceU and a 15% decrease in the fibrU unit ceU with age. Both 
would result in a significant overaU decrease in. the extrafibriUaj space 
where most of the proteoglycans are situated. The regular interfibriUar 
spacing of constant diameter fibrils appears to be vital for transparency and
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the regular arrangement of the proteoglycans along the collagen fibril must 
contribute to this. It is suggested that proteoglycan:collagen interactions 
keep fibrils apart and hold them in definite orientations. Keratan sulphate 
concentrations have been found to increase with corneal thickness whilst 
dermatan sulphate decreases. However, a significant thinning of the corneal 
periphery has been reported together with a decrease in the ratio of 
peripheral to central corneal thickness after 50 years of age [Martola and 
Baum, 1968]. Natural age-associated alterations in proteoglycan 
concentrations may weU be responsible for the reduction in (interfibriUar 
spacing)^ with corneal age. From the SDS-PAGE and electron microscope 
studies on the corneal incubation medium (Chapter 4) indicating that the 
culture medium did not induce significant proteoglycan loss, the. decrease in 
the size of the fibrU unit ceU of human corneal coUagen is an age-related 
occurrence.
The effect of glycation on proteoglycan structure was not studied here. 
However, if there is an alteration in the degree of sulphation, hence charge 
of proteoglycans, the proteoglycan-coUagen interactions would be affected 
and these would in turn alter the assembly and function of the coUagen 
matrix.
Bai et al (l992) have recently suggested, through electron microscopical 
observations, that the glycation of rat tail tendon coUagen results in close 
packing of fibrils. Although proteoglycans are commonly associated with 
maintaining precise spatial relationships between coUagen fibrils, it is 
possible that the process of glycation causes ‘fibril fusion’ suggesting that 
cross-hnking is occurring between coUagen molecules in different fibrils.
This ha^ not yet been observed in other coUagenous tissues.
Glycation and proteoglycan composition/type alterations result in changes 
in electrical charge on the coUagen molecule and along the fibril. The 
outcome would be sweUing of the coUagen fibrils which would in turn 
reduce the extrafibriUar space, i.e. a reduction in the size of the fibril unit 
ceU. It is probable that no one phenomenon is entirely responsible for the 
change in this particular parameter and therefore Hkely that they each play
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a role in this age-related alteration.
9.1 Suggestions for further study
After a study of this type, where most of the parameters investigated are 
the first to be reported for corneal and scleral type I collagen and for 
several other collagen types, there is great scope for further work. Amongst 
the possibilities are the following :
1) It would be appropriate to locate the sites of AGE cross-Hnking along 
the collagen fibril possibly by investigating changes in the electron density 
along the fibrils resulting from AGE formation. As yet, no observations 
have been made concerning changes in the meridional X-ray pattern as a 
function of age or glycation. Such changes would be expected if the axial 
electron density of corneal and scleral collagen was affected by cross-hnking.
2) Since inhibitors of glycation and AGE production have been used to 
hmit the alteration in the molecular unit ceU size, it would be of interest to 
investigate the use of naturally-occurring compounds, such as vitamin C 
(ascorbate), the concentration of which is known to decrease in human 
cornea, in the same context.
3) An age-related study of changes in the iron and copper ion 
concentrations of corneal and scleral tissues is required in order to see 
whether metal-catalysed oxidative reactions are playing a significant role in 
AGE formation.
4) A comprehensive study of the level of proteoglycans in both the human 
cornea and sclera is required as a function of age, since these 
macromolecules are known to be involved in interfibriUar separations.
5) The effect of glycation on proteoglycan structure and proteoglycan levels 
needs to be investigated since, any alteration in the charge of
glycosaminoglycans, would affect the behaviour of the collagen-containing 
matrix in both cornea and sclera and other connective tissues. .
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